<SEC-DOCUMENT>0001193125-24-089610.txt : 20240408
<SEC-HEADER>0001193125-24-089610.hdr.sgml : 20240408
<ACCEPTANCE-DATETIME>20240408160606
ACCESSION NUMBER:		0001193125-24-089610
CONFORMED SUBMISSION TYPE:	424B7
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20240408
DATE AS OF CHANGE:		20240408

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TD SYNNEX CORP
		CENTRAL INDEX KEY:			0001177394
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-COMPUTER & PERIPHERAL EQUIPMENT & SOFTWARE [5045]
		ORGANIZATION NAME:           	07 Trade & Services
		IRS NUMBER:				942703333
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1130

	FILING VALUES:
		FORM TYPE:		424B7
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-274915
		FILM NUMBER:		24829624

	BUSINESS ADDRESS:	
		STREET 1:		44201 NOBEL DRIVE
		CITY:			FREMONT
		STATE:			CA
		ZIP:			94538
		BUSINESS PHONE:		5106563333

	MAIL ADDRESS:	
		STREET 1:		44201 NOBEL DRIVE
		CITY:			FREMONT
		STATE:			CA
		ZIP:			94538

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SYNNEX CORP
		DATE OF NAME CHANGE:	20211102

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TD SYNNEX CORP
		DATE OF NAME CHANGE:	20211102

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SYNNEX CORP
		DATE OF NAME CHANGE:	20031106
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B7
<SEQUENCE>1
<FILENAME>d776938d424b7.htm
<DESCRIPTION>424B7
<TEXT>
<HTML><HEAD>
<TITLE>424B7</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Filed Pursuant to Rule 424(b)(7)<BR>Registration No. 333-274915 </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>PROSPECTUS SUPPLEMENT </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>5,309,299 Shares </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g776938g04a04.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:7pt; margin-bottom:0pt; font-size:22pt; font-family:Times New Roman" ALIGN="center"><B>TD SYNNEX Corporation </B></P>
<P STYLE="margin-top:7pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P> <P STYLE="font-size:7pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:7pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman">This prospectus supplement
relates to the resale of up to an aggregate of 5,309,299 shares of common stock of TD SYNNEX Corporation, a Delaware corporation, by certain entities managed by affiliates of Apollo Global Management, Inc. (the &#147;Selling Stockholders&#148;),
which represent all the remaining shares owned by the Selling Stockholders. Pursuant to Rule 429 under the Securities Act of 1933, as amended, the prospectus dated October&nbsp;10, 2023, as supplemented by this prospectus supplement, is a combined
prospectus relating to (a)&nbsp;up to 35,199,549 shares of our common stock previously registered for resale by the Selling Stockholders pursuant to the registration statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-3</FONT> filed on
September&nbsp;2, 2021 (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-259270)</FONT> and (b)&nbsp;up to 9,762,063 shares of our common stock registered for resale by other selling stockholders pursuant to the registration statement on <FONT
STYLE="white-space:nowrap">Form&nbsp;S-3</FONT> filed on October&nbsp;10, 2023 (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-274915).</FONT> We are not selling any shares of our common stock under this prospectus and we will not receive any of
the proceeds from the sale of shares by the Selling Stockholders. Our common stock is listed on The New York Stock Exchange (the &#147;NYSE&#148;) under the symbol &#147;SNX.&#148; On April&nbsp;4, 2024, the last reported sale price for our common
stock on the NYSE was $117.26&nbsp;per share. </P> <P STYLE="margin-top:7pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman">We intend to purchase from the underwriters 1,750,000 shares of our common stock offered in this offering,
at a price per share equal to the price per share to be paid by the underwriters to the Selling Stockholders, as part of our existing stock repurchase program (the &#147;Concurrent Share Repurchase&#148;). See &#147;Concurrent Share
Repurchase,&#148; beginning on <FONT STYLE="white-space:nowrap">page&nbsp;S-8</FONT> of this prospectus supplement. </P> <P STYLE="font-size:7pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:7pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our business and an
investment in our common stock involve significant risks. These risks are described under the caption &#147;<A HREF="#s776938_4">Risk Factors</A>&#148; beginning on page <FONT STYLE="white-space:nowrap">S-5</FONT> of this prospectus supplement, as
well as those contained in the accompanying prospectus and in the documents incorporated by reference herein. </B></P> <P STYLE="font-size:7pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:7pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman"><B>Neither the Securities and
Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus. Any representation to the contrary is a criminal offense. </B></P>
<P STYLE="margin-top:7pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman">The underwriters have agreed to purchase the shares of common stock at a price of $114.20&nbsp;per share, which will result in approximately $606,321,946 of
net proceeds (before deducting expenses) to the Selling Stockholders. The underwriters may offer the shares of common stock from time to time for sale directly or through agents, or through brokers in one or more brokerage transactions on the NYSE,
or to dealers in negotiated transactions or in a combination of such methods of sale, at a fixed price or prices, which may be changed, or at market prices prevailing at the time of sale, at prices related to prevailing market prices or at
negotiated prices, subject to their right to reject any order in whole or in part. See &#147;Underwriting (Conflict of Interest)&#148;. </P> <P STYLE="margin-top:7pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman">References to
&#147;underwriters&#148; in this prospectus supplement refer to the underwriters named in the &#147;Underwriting (Conflict of Interest)&#148; section of this prospectus supplement. </P>
<P STYLE="margin-top:7pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman">The underwriters expect to deliver the shares against payment in New York, New York on or approximately April&nbsp;9, 2024. </P>
<P STYLE="font-size:7pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:7pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Book-Running Managers </I></B></P> <P STYLE="font-size:7pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt">


<TR>

<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="14%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="26%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:12pt; font-family:Times New Roman"><B>J.P.&nbsp;Morgan</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Citigroup</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:12pt; font-family:Times New Roman" ALIGN="right"><B>Goldman&nbsp;Sachs&nbsp;&amp;&nbsp;Co.&nbsp;LLC</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><B>Mizuho</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><B>RBC&nbsp;Capital&nbsp;Markets</B></TD></TR>
</TABLE> <P STYLE="font-size:7pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:7pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B>April&nbsp;4, 2024 </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>Prospectus Supplement</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#s776938_1">About This Prospectus Supplement</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-ii</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#s776938_2">Prospectus Supplement Summary</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-1</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#s776938_3">The Offering</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-3</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#s776938_4">Risk Factors</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-5</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#s776938_5">Cautionary Note Concerning Forward-Looking Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-7</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#s776938_6">Concurrent Share Repurchase</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-8</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#s776938_7">Use of Proceeds</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-9</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#s776938_8">Selling Stockholders</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-10</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#s776938_9">Material U.S. Federal Income Tax Consequences to <FONT
STYLE="white-space:nowrap">Non-U.S.</FONT> Holders</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-13</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#s776938_10">Underwriting (Conflict of Interest)</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-17</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#s776938_11">Legal Matters</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-23</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#s776938_12">Experts </A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-23</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#s776938_13">Where You Can Find More Information</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-24</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#s776938_14">Incorporation Of Information By Reference</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-25</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>Prospectus</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx776938_1">About this Prospectus</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">ii</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx776938_2">Prospectus Summary</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx776938_3">Risk Factors</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx776938_4">Forward-Looking Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx776938_5">Use of Proceeds</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx776938_6">Selling Stockholders</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx776938_7">Material Relationships with Selling Stockholders</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx776938_8">Plan of Distribution</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx776938_9">Legal Matters</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx776938_10">Experts</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx776938_11">Where You Can Find More Information</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx776938_12">Incorporation of Certain Documents by Reference</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="s776938_1"></A>ABOUT THIS PROSPECTUS SUPPLEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This document is part of a registration statement that was filed with the Securities and Exchange Commission, or the SEC, using a
&#147;shelf&#148; registration process and consists of two parts. The first part is this prospectus supplement, which describes the specific terms of this offering and also supplements and updates information contained in the accompanying prospectus
and the documents incorporated by reference into this prospectus supplement and the accompanying prospectus. The second part is the accompanying prospectus, which provides more general information, some of which may not apply to this offering. This
prospectus supplement may add, update, or change information contained in the accompanying prospectus. Generally, when we refer to this prospectus, we are referring to both parts of this document combined. In addition, in this prospectus, as
permitted by law, we &#147;incorporate by reference&#148; information from other documents that we file with the SEC. This means that we can disclose important information to you by referring you to those documents. The information incorporated by
reference is considered to be a part of this prospectus supplement and the accompanying prospectus and should be read with the same care. When we update the information contained in documents that have been incorporated by reference by making future
filings with the SEC, the information included or incorporated by reference in this prospectus supplement is considered to be automatically updated and superseded. If the information contained in this prospectus supplement differs or varies from, or
is inconsistent with, the information contained in the accompanying prospectus, or the information contained in any document incorporated by reference that was filed with the SEC before the date of this prospectus supplement, you should rely on the
information set forth in this prospectus supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Neither we, the Selling Stockholders, nor the underwriters have authorized anyone
else to provide you with information that is in addition to or different from that contained or incorporated by reference in this prospectus supplement and the accompanying prospectus, along with the information contained in any permitted free
writing prospectuses we have authorized for use in connection with this offering. Neither we, the Selling Stockholders, nor the underwriters take any responsibility for, and can provide any assurance as to the reliability of, any other information
that others may provide. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The information contained in this prospectus supplement and the accompanying prospectus is accurate only as of
the date of this prospectus supplement or the date of the accompanying prospectus, and the information in the documents incorporated by reference in this prospectus supplement and the accompanying prospectus is accurate only as of the date of those
respective documents, regardless of the time of delivery of this prospectus supplement and the accompanying prospectus or of any sale of our common stock. Our business, financial condition, results of operations and prospects may have changed since
those dates. It is important for you to read and consider all information contained or incorporated by reference in this prospectus supplement and the accompanying prospectus in making your investment decision. You should read both this prospectus
supplement and the accompanying prospectus, as well as the documents incorporated by reference into this prospectus supplement and the accompanying prospectus and the additional information described under &#147;Where You Can Find More
Information&#148; in this prospectus supplement and in the accompanying prospectus before investing in our common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We further note
that the representations, warranties, and covenants made by us in any agreement that is filed as an exhibit to any document that is incorporated by reference in this prospectus supplement and the accompanying prospectus were made solely for the
benefit of the parties to such agreement, including, in some cases, for the purpose of allocating risk among the parties to such agreements, and should not be deemed to be a representation, warranty or covenant to you. Moreover, such
representations, warranties or covenants were accurate only as of the date when made. Accordingly, such representations, warranties, and covenants should not be relied on as accurately representing the current state of our affairs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We use various trademarks and trade names in our business, including without limitation our corporate name and logo. All other trademarks or
trade names referred to in this prospectus supplement and the accompanying prospectus and the documents incorporated by reference herein or therein are the property of their </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
respective owners. Solely for convenience, the trademarks and trade names in this prospectus supplement and the accompanying prospectus and the documents incorporated by reference herein or
therein may be referred to without the <SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> and <SUP STYLE="font-size:75%; vertical-align:top">&#153;</SUP> symbols, but such references should not be construed as any indicator that their
respective owners will not assert, to the fullest extent under applicable law, their rights thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should not consider this
prospectus supplement or the accompanying prospectus to be an offer or solicitation relating to the securities in any jurisdiction in which such an offer or solicitation relating to the securities is not authorized. Persons outside the United States
who come into possession of this prospectus supplement and the accompanying prospectus must inform themselves about, and observe any restrictions relating to, the offering of the securities and the distribution of this prospectus supplement and the
accompanying prospectus outside the United States. This prospectus supplement and the accompanying prospectus do not constitute, and may not be used in connection with, an offer to sell, or a solicitation of an offer to buy, any securities offered
by this prospectus supplement or the accompanying prospectus supplement by any person in any jurisdiction if the person making the offer or solicitation is not qualified to do so, or if it is unlawful for you to receive such an offer or
solicitation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise indicated, information contained in or incorporated by reference into this prospectus supplement and the
accompanying prospectus concerning our business and the industry and markets in which we operate, including with respect to our business prospects, our market position and opportunity, and the competitive landscape, is based on information from our
management&#146;s estimates, as well as from industry publications, surveys and studies conducted by third parties. Our management&#146;s estimates are derived from publicly available information, their knowledge of our business and industry, and
assumptions based on such information and knowledge, which they believe to be reasonable. In addition, while we believe that information contained in the industry publications, surveys and studies has been obtained from reliable sources, we have not
independently verified any of the data contained in these third-party sources, and the accuracy and completeness of the information contained in these sources is not guaranteed. Information that is based on estimates, forecasts, projections, market
research or similar methodologies is inherently subject to uncertainties and actual events or circumstances may differ materially from events and circumstances reflected in this information. Unless otherwise expressly stated, we obtained this
industry, business, market, and other data from reports, research surveys, studies and similar data prepared by market research firms and other third parties, industry, medical, and general publications, government data and similar sources. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In this prospectus supplement, except as otherwise indicated or unless the context otherwise requires, (i)&nbsp;both &#147;Issuer&#148; and
&#147;TD SYNNEX&#148; refer to TD SYNNEX Corporation and not to any of its subsidiaries, and (ii) &#147;we,&#148; &#147;us,&#148; &#147;our,&#148; and the &#147;Company&#148; each refer to TD SYNNEX Corporation and its subsidiaries. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-iii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="s776938_2"></A>PROSPECTUS SUPPLEMENT SUMMARY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>This summary highlights selected information from this prospectus supplement, the accompanying prospectus, or incorporated by reference
herein and therein, and is therefore qualified in its entirety by the more detailed information appearing elsewhere, or incorporated by reference, in this prospectus supplement or the accompanying prospectus. Because it is a summary, it does not
contain all the information that you should consider before investing. Before investing in our common stock, you should read this entire prospectus supplement and the accompanying prospectus carefully, including the &#147;Risk Factors,&#148; and the
financial statements and accompanying notes and other information incorporated by reference in this prospectus supplement and the accompanying prospectus. </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Company Overview </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are a Fortune 100
corporation and a leading provider of a comprehensive range of distribution, systems design, and integration services for the technology industry. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We distribute PC systems, mobile phones and accessories, printers, peripherals, information technology (&#147;IT&#148;) systems including data
center server and storage solutions, system components, software, networking, communications and security equipment, consumer electronics and complementary products. We also provide systems design and integration solutions. We distribute more than
200,000 technology products (as measured by active SKUs) from more than 2,500 original equipment manufacturers, as well as suppliers of next-generation technologies and delivery models such as converged and hyper-converged infrastructure, the cloud,
security, big data/analytics/Internet of things, artificial intelligence and services. Our products are marketed globally to an active reseller base of more than 150,000 resellers, system integrators, and retailers. We purchase peripherals, IT
systems, system components, software, networking, communications and security equipment and complementary products from our suppliers and sell them to our reseller and retail customers. We perform a similar function for our distribution of licensed
software products. Our reseller customers include value-added resellers, corporate resellers, government resellers, system integrators, direct marketers, retailers and managed service providers. We provide our vendors with access to large and highly
fragmented markets such as small- and <FONT STYLE="white-space:nowrap">medium-sized</FONT> businesses and serve as a variable, cost effective route to market for our vendors by providing them with access to resellers and <FONT
STYLE="white-space:nowrap">end-users.</FONT> We combine our core strengths in distribution with demand generation, supply chain management and design and integration solutions to help our customers achieve greater efficiencies in time to market,
cost minimization, real-time linkages in the supply chain and aftermarket product support. We also provide comprehensive IT solutions in key vertical markets such as government and healthcare and we provide specialized service offerings that
increase efficiencies in the areas of global computing components, logistics services and supply chain management. Additionally, we provide our customers with systems design and integration solutions for data center servers and networking solutions
built specific to our customers&#146; workloads and data center environments. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Corporate Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have been in business since 1980 and have headquarters in both Clearwater, Florida and Fremont, California. We were originally incorporated
in the State of California as COMPAC Microelectronics, Inc. in November 1980, and we changed our name to SYNNEX Information Technologies, Inc. in February 1994. We later reincorporated in the State of Delaware under the name of SYNNEX Corporation in
October 2003. On October&nbsp;22, 2021, as a result of the Mergers (as defined below), we filed with the Secretary of State of the State of Delaware a Certificate of Amendment to the Company&#146;s Restated Certificate of Incorporation to change our
corporate name from SYNNEX Corporation to TD SYNNEX Corporation, effective November&nbsp;3, 2021. Our common stock is listed on The New York Stock Exchange under the symbol &#147;SNX.&#148; Our principal executive offices are located at 44201 Nobel
Drive, Fremont, California 94538, and our telephone number is <FONT STYLE="white-space:nowrap">(510)&nbsp;656-3333.</FONT> </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Merger Transactions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;1, 2021, we completed our acquisition of Tiger Parent (AP) Corporation, a Delaware Corporation (&#147;Tiger Parent&#148;),
which is the parent corporation of Tech Data Corporation, a Florida corporation (&#147;Tech Data&#148;). The acquisition was completed pursuant to the terms and conditions of the Agreement and Plan of Merger (the &#147;Merger Agreement&#148;), dated
March&nbsp;22, 2021 by and among SYNNEX Corporation, Spire Sub I, Inc., a Delaware corporation and a wholly owned subsidiary of SYNNEX Corporation (&#147;Merger Sub I&#148;), Spire Sub II, LLC, a Delaware limited liability company and a wholly owned
subsidiary of SYNNEX Corporation (&#147;Merger Sub II&#148;), and Tiger Parent, pursuant to which, subject to the terms and conditions of the Merger Agreement, Merger Sub I merged with and into Tiger Parent (the &#147;Initial Merger&#148;), with
Tiger Parent surviving the Initial Merger as a wholly owned subsidiary of SYNNEX Corporation (such surviving corporation, the &#147;Surviving Corporation&#148;), followed immediately by the merger of the Surviving Corporation with and into Merger
Sub II (the &#147;Subsequent Merger&#148; and together with the Initial Merger, the &#147;Mergers&#148;), with Merger Sub&nbsp;II surviving the Subsequent Merger as a wholly owned subsidiary of SYNNEX Corporation. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Recent Developments </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cash Dividends to
Common Stockholders </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&nbsp;26, 2024, we announced a cash dividend of $0.40 per share to stockholders of record as of
April&nbsp;12, 2024, payable on April&nbsp;26, 2024. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Concurrent Share Repurchase </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We regularly evaluate alternatives to deliver value to our stockholders and optimize our capital structure, including alternatives that utilize
our existing stock repurchase program, under which we are authorized to repurchase up to $2.142&nbsp;billion of shares of our common stock as of April 2, 2024. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We intend to purchase from the underwriters 1,750,000&nbsp;shares of our common stock offered in this offering, at a price per share equal to
the price per share to be paid by the underwriters to the Selling Stockholders, as part of our existing stock repurchase program (the &#147;Concurrent Share Repurchase&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The terms and conditions of the Concurrent Share Repurchase were reviewed and approved by the audit committee of our board of directors,
comprised of independent and disinterested directors. The Concurrent Share Repurchase will be made under our existing share repurchase program and will reduce the remaining amount available for purchase. The Concurrent Share Repurchase will be
funded from our existing cash on hand. The underwriters will not receive any compensation for the shares being repurchased by us. See &#147;Concurrent Share Repurchase,&#148; beginning on <FONT STYLE="white-space:nowrap">page&nbsp;S-8</FONT> of this
prospectus supplement. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="s776938_3"></A>THE OFFERING </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Common stock offered by the Selling Stockholders </P></TD>
<TD>5,309,299 shares. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Concurrent Share Repurchase </P></TD>
<TD>We intend to purchase from the underwriters 1,750,000&nbsp;shares of our common stock offered in this offering, at a price per share equal to the price per share to be paid by the underwriters to the Selling Stockholders, as part of our existing
stock repurchase program. The underwriters will not receive any compensation for the shares being repurchased by us in the Concurrent Share Repurchase. See &#147;Concurrent Share Repurchase.&#148; </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Common stock to be outstanding immediately after the offering and the Concurrent Share Repurchase </P></TD>
<TD>85,399,786&nbsp;shares (assuming we repurchase 1,750,000&nbsp;shares in the Concurrent Share Repurchase). </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Use of proceeds </P></TD>
<TD>All of the shares of common stock being offered under this prospectus are being sold by the Selling Stockholders. Accordingly, we will not receive any proceeds from the sale of these shares. </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Dividend </P></TD>
<TD>We have declared a dividend of $0.40 per share to holders of record as of April&nbsp;12, 2024, payable on April&nbsp;26, 2024. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Risk factors </P></TD>
<TD>Investing in our common stock involves significant risks. See &#147;Risk Factors&#148; on <FONT STYLE="white-space:nowrap">page&nbsp;S-5</FONT> of this prospectus supplement and under similar headings in the documents incorporated by reference
into this prospectus supplement and the accompanying prospectus for a discussion of the factors you should carefully consider before deciding to invest in our common stock. </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Conflict of Interest </P></TD>
<TD>Apollo Global Securities, LLC (&#147;AGS&#148;) has a &#147;conflict of interest&#148; within the meaning of FINRA Rule 5121 in this offering because AGS is affiliated with the Selling Stockholders, who are in turn our affiliates, and because
the net proceeds of this offering will be received by the Selling Stockholders. Accordingly, this offering will be conducted in accordance with the requirements of Financial Industry Regulation Authority (&#147;FINRA&#148;) Rule 5121 regarding a
FINRA member firm&#146;s participation in a public offering of securities of an affiliate. Pursuant to that rule, the appointment of a &#147;qualified independent underwriter&#148; is not required in connection with this offering. In accordance with
FINRA Rule 5121, neither AGS nor any other affiliated underwriter, agent or dealer may sell the securities to any account over which it exercises discretionary authority without the specific written approval of the account holder. </TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The number of shares of common stock that will be outstanding immediately after this offering and the
Concurrent Share Repurchase is based on 87,149,786&nbsp;shares of common stock outstanding, which reflects 87,649,786&nbsp;shares outstanding as of February&nbsp;29, 2024 and gives effect to our repurchase of 500,000&nbsp;shares as part of the
secondary offering by the Selling Stockholders completed on April&nbsp;2, 2024, and excludes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">561,232 shares of common stock issuable upon the exercise of options outstanding as of February&nbsp;29, 2024;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">500,118 shares of common stock issuable upon vesting of restricted stock units outstanding as of
February&nbsp;29, 2024; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">3,981,892 shares of common stock reserved for future issuance as of February&nbsp;29, 2024 under our compensation
plans. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Except as otherwise noted, the information in this prospectus supplement assumes no exercise of the outstanding options or
vesting of the restricted stock units described above. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="s776938_4"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Investing in our common stock involves a high degree of risk. Before making an investment decision, you should carefully consider the risks
described below and in our most recent Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> and subsequent Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> or Current Reports on Form
<FONT STYLE="white-space:nowrap">8-K,</FONT> as well as any amendments thereto reflected in subsequent filings, each of which are incorporated by reference in this prospectus supplement and the accompanying prospectus, and all of the other
information in this prospectus supplement and the accompanying prospectus, including our financial statements and related notes incorporated by reference in this prospectus supplement and the accompanying prospectus. If any of these risks is
realized, our business, financial condition, results of operations and prospects could be materially and adversely affected. In that event, the trading price of our common stock could decline, and you could lose part or all of your investment.
Additional risks and uncertainties that are not yet identified or that we think are immaterial may also materially harm our business, operating results and financial condition and could result in a complete loss of your investment. </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Sales or the availability for sale of a substantial number of shares of our common stock in the public market could cause our stock price to be volatile
or fall. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Sales of a substantial number of shares of our common stock in the public market or the perception that these sales might
occur could abruptly depress the market price of our common stock and could impair our ability to raise capital through the sale of additional equity securities. As of April 2, 2024, we had approximately 87,149,786 shares of our common stock
outstanding (based on 87,649,786 shares outstanding as of February 29, 2024 and after giving effect to our repurchase of 500,000 shares as part of the secondary offering by the Selling Stockholders completed on April 2, 2024), 5,309,299 of which is
held by the Selling Stockholders. We have agreed that, for a period of 30 days after the date of this prospectus, we will not, without the prior written consent of J.P. Morgan Securities LLC, dispose of any shares of our common stock or any
securities convertible into or exchangeable for our common stock, subject to certain exceptions. In addition, in connection with a prior offering of shares by the Selling Stockholders that closed on April 2, 2024, the Selling Stockholders and all of
our executive officers and directors agreed, subject to certain exceptions, not to dispose of or hedge any of their common stock or securities convertible into or exchangeable for shares of common stock through April 26, 2024, except with the prior
written consent of J.P. Morgan Securities LLC. J.P. Morgan Securities LLC has provided a waiver with respect to those lock-up agreements signed by the Selling Stockholders to permit the Selling Stockholders to sell the 5,309,299 shares of common
stock offered hereby. See &#147;Underwriting (Conflict of Interest).&#148; Following the expiration of the applicable <FONT STYLE="white-space:nowrap">lock-up</FONT> period, all of the issued and outstanding shares of our common stock will be
eligible for future sale, subject to applicable volume, manner of sale, holding periods, and other limitations of Rule&nbsp;144. J.P. Morgan Securities LLC may, in its sole discretion, release all or any portion of the shares subject to <FONT
STYLE="white-space:nowrap">lock-up</FONT> agreements at any time and for any reason. In addition, certain of our shareholders have certain registration rights that require us to register the sale of common stock held by them, including in connection
with underwritten offerings. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The availability for sale of a large number of shares of our common stock in the public market upon
expiration of the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements, or the early release of any <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements, could increase the potential for stock price volatility or cause the price of our
common stock to decline. Even if we put strategies in place to attempt to address potential or actual volatility, the effectiveness of such strategies is uncertain. Further, we are currently assessing our debt structure ahead of our upcoming
$700&nbsp;million debt maturity in August of this year, and we currently intend to refinance some or all of the debt prior to its maturity, which in turn may impact our stock price. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our bylaws provide that the Court of Chancery of the State of Delaware will be the exclusive forum for substantially all disputes between us and our
stockholders, which could limit our stockholders&#146; ability to obtain a favorable judicial forum for disputes with us or our directors, officers or employees. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our bylaws provide that the Court of Chancery of the State of Delaware (or, if the Court of Chancery does not have jurisdiction, the federal
district court for the District of Delaware) is the exclusive forum for (i)&nbsp;any derivative action or proceeding brought on behalf of the corporation, (ii)&nbsp;any action asserting a claim of breach of
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
fiduciary duty owed by any current or former director, officer, other employee or agent of the corporation to the corporation or the corporation&#146;s stockholders, including a claim alleging
the aiding and abetting of such a breach of fiduciary duty, (iii)&nbsp;any action asserting a claim arising pursuant to any provision of the Delaware General Corporation Law or the bylaws or the certificate of incorporation or (iv)&nbsp;any action
asserting a claim governed by the internal affairs doctrine or asserting an &#147;internal corporate claim&#148;. This choice of forum provision may limit a stockholder&#146;s ability to bring a claim in a different judicial forum that such
stockholder views as more favorable for such disputes which may discourage such lawsuits against us and our directors, officers and other employees. Alternatively, if a court were to find the choice of forum provisions contained in our bylaws to be
inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could adversely affect our business and financial condition. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="s776938_5"></A>CAUTIONARY NOTE CONCERNING FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Forward-looking statements included in this prospectus or information and other documents incorporated by reference herein are based on
various facts and derived utilizing numerous important assumptions and are subject to known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future
results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements include the information concerning our future financial performance, business strategy, projected plans and objectives, as well
as projections of macroeconomic and industry trends, which are inherently unreliable due to the multiple factors that impact economic trends, and any such variations may be material. Statements preceded by, followed by or that otherwise include
terms such as &#147;believes,&#148; &#147;expects,&#148; &#147;anticipates,&#148; &#147;intends,&#148; &#147;projects,&#148; &#147;estimates,&#148; &#147;plans,&#148; and similar or the negative of such expressions or future or conditional verbs
such as &#147;will,&#148; &#147;should,&#148; &#147;would,&#148; &#147;may&#148; and &#147;could&#148; are generally forward looking in nature and not historical facts. You should not place undue reliance on these forward-looking statements. We
discuss in greater detail in, and in the documents incorporated by reference into, this prospectus supplement and the accompanying prospectus, many of these risks, uncertainties, and assumptions, including under the heading &#147;Risk Factors.&#148;
Additional cautionary statements or discussions of risks, uncertainties and assumptions that could cause our actual results to differ materially from those described in the forward-looking statements include, but are not limited to, those discussed
in the section entitled &#147;Risk Factors&#148; beginning on page 4 of the prospectus, and under Part I, Item 1A, Risk Factors, of our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the period ended November&nbsp;30, 2023
incorporated by reference in this prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any forward-looking statement made by us in this prospectus supplement, the accompanying
prospectus, or any of the documents incorporated by reference in this prospectus supplement and the accompanying prospectus speaks only as of the date on which it was made. Except as required by law, we expressly disclaim any obligation or
undertaking to release publicly any updates or revisions to any forward- looking statements contained herein to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such
statement is based. You should, however, review additional disclosures we make in our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K,</FONT> Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q,</FONT> and Current Reports on
Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed with the SEC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should read this prospectus supplement, the accompanying
prospectus, and the documents that we incorporated by reference in this prospectus supplement and the accompanying prospectus completely and with the understanding that our actual future results, levels of activity and performance as well as other
events and circumstances may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="s776938_6"></A>CONCURRENT SHARE REPURCHASE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We intend to purchase from the underwriters 1,750,000 shares of our common stock offered in this offering, at a price per share equal to the
price per share to be paid by the underwriters, to the Selling Stockholders as part of our existing stock repurchase program. The terms and conditions of the Concurrent Share Repurchase were reviewed and approved by the audit committee of our board
of directors, comprised of independent and disinterested directors. The Concurrent Share Repurchase will be made under our existing share repurchase program and will reduce the remaining amount available for purchase. The Concurrent Share Repurchase
will be funded from our existing cash on hand. The underwriters will not receive any compensation for the shares being repurchased by us. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="s776938_7"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All of the shares of common stock being offered hereby are being sold by the Selling Stockholders identified in this prospectus supplement. We
will not receive any proceeds from the sale of the shares of common stock by the Selling Stockholders. The Selling Stockholders will receive all of the net proceeds from this offering. We have agreed to pay all expenses relating to registering the
shares of common stock. See &#147;Selling Stockholders.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="s776938_8"></A>SELLING STOCKHOLDERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth information regarding the beneficial ownership of our shares of common stock as of February&nbsp;29, 2024
(after giving effect to the secondary offering by the Selling Stockholders completed on April&nbsp;2, 2024 and our repurchase of 500,000 shares as part of such secondary offering), before and after giving effect to this offering by the Selling
Stockholders (including the Concurrent Share Repurchase). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The amounts and percentages of shares beneficially owned are reported on the
basis of rules and regulations of the SEC governing the determination of beneficial ownership of securities. Under rules of the SEC, a person is deemed to be a &#147;beneficial owner&#148; of a security if that person has or shares voting power or
investment power, which includes the power to dispose of or to direct the disposition of such security. A person is also deemed to be a beneficial owner of any securities of which that person has a right to acquire beneficial ownership within
60&nbsp;days. Securities that can be so acquired are deemed to be outstanding for purposes of computing such person&#146;s ownership percentage, but not for purposes of computing any other person&#146;s percentage. Under these rules, more than one
person may be deemed to be a beneficial owner of the same securities, and a person may be deemed to be a beneficial owner of securities as to which such person has no economic interest. The address for the beneficial owner is set forth in the
footnote to the table. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Percentage computations are based on 87,149,786 shares of our common stock outstanding, which reflects 87,649,786
shares outstanding as of February 29, 2024 and after giving effect to our repurchase of 500,000 shares as part of the secondary offering by the Selling Stockholders completed on April&nbsp;2, 2024, before giving effect to the Concurrent Share
Repurchase, and 85,399,786 shares of our common stock outstanding after giving effect to the repurchase of 1,750,000 shares in the Concurrent Share Repurchase. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="53%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares&nbsp;of&nbsp;Common<BR>Stock&nbsp;Beneficially&nbsp;Owned<BR>Before&nbsp;the&nbsp;Offering&nbsp;and&nbsp;the<BR>Concurrent&nbsp;Share&nbsp;
Buyback</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares&nbsp;of<BR>Common<BR>Stock to be<BR>Sold in the<BR>Offering&nbsp;<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares&nbsp;of&nbsp;Common&nbsp;Stock<BR>Beneficially&nbsp;Owned&nbsp;After<BR>the&nbsp;Offering&nbsp;(Including&nbsp;in<BR>Connection with
the<BR>Concurrent Share<BR>Buyback)&nbsp;<SUP STYLE="font-size:75%; vertical-align:top">(2)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percent</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percent</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities managed by affiliates of Apollo Global Management, Inc.&nbsp;<SUP
STYLE="font-size:75%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,309,299</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.1</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,309,299</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents the number of shares offered by the Selling Stockholders pursuant to this prospectus supplement.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Assumes that each Selling Stockholder disposes of all of the shares of common stock covered by this prospectus
supplement and does not acquire beneficial ownership of any additional shares. This also gives effect to the Concurrent Share Repurchase. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">AP IX Tiger Holdings, L.P. (&#147;AP IX Tiger&#148;), AP IX Tiger
<FONT STYLE="white-space:nowrap">Co-Invest</FONT> II, L.P. (&#147;Tiger <FONT STYLE="white-space:nowrap">Co-Invest&#148;)</FONT> and AP IX Tiger <FONT STYLE="white-space:nowrap">Co-Invest</FONT> (ML), L.P. (&#147;Tiger
<FONT STYLE="white-space:nowrap">Co-Invest</FONT> ML&#148;) each hold shares of the Company. The shares of common stock to be sold in this offering are held by AP IX Tiger, Tiger <FONT STYLE="white-space:nowrap">Co-Invest</FONT> and Tiger <FONT
STYLE="white-space:nowrap">Co-Invest</FONT> ML. AP IX Tiger <FONT STYLE="white-space:nowrap">Co-Invest</FONT> (ML)&nbsp;GP, LLC (&#147;Tiger <FONT STYLE="white-space:nowrap">Co-Invest</FONT> ML GP&#148;) is the general partner of Tiger <FONT
STYLE="white-space:nowrap">Co-Invest</FONT> ML. AP IX Tiger Holdings GP, LLC (&#147;AP IX Tiger GP&#148;) is the general partner of each of AP IX Tiger and Tiger <FONT STYLE="white-space:nowrap">Co-Invest,</FONT> and the sole member of Tiger <FONT
STYLE="white-space:nowrap">Co-Invest</FONT> ML GP. Apollo Management IX, L.P. (&#147;Management IX&#148;) is the <FONT STYLE="white-space:nowrap">non-member</FONT> manager of AP IX Tiger GP. The general partner of Management IX is AIF IX Management,
LLC (&#147;AIF IX LLC&#148;). Apollo Management, L.P. (&#147;Apollo LP&#148;) is the sole member and manager of AIF IX LLC. Apollo Management GP, LLC (&#147;Management GP&#148;) is the general partner of Apollo LP. Apollo Management Holdings, L.P.
(&#147;Management Holdings&#148;) is the sole member of Management GP. Apollo Management Holdings GP, LLC (&#147;Management Holdings GP&#148;) is the general partner of Management Holdings. Each of the entities listed herein, other than AP IX Tiger,
Tiger <FONT STYLE="white-space:nowrap">Co-Invest,</FONT> and Tiger <FONT STYLE="white-space:nowrap">Co-Invest</FONT> ML, disclaims beneficial ownership of any shares of the common stock owned of record by AP IX Tiger, Tiger <FONT
STYLE="white-space:nowrap">Co-Invest,</FONT> and Tiger <FONT STYLE="white-space:nowrap">Co-Invest</FONT> ML, except to the extent of any pecuniary interest therein. The address of the principal office of each of Tiger
<FONT STYLE="white-space:nowrap">Co-Invest</FONT> ML GP and AP IX Tiger GP is One Manhattanville Road, Suite 201, Purchase, New York 10577. The address of the principal </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
office of each of AP IX Tiger, Tiger <FONT STYLE="white-space:nowrap">Co-Invest,</FONT> Tiger <FONT STYLE="white-space:nowrap">Co-Invest</FONT> ML, and Management Holdings is One Manhattanville
Road, Suite 201, Purchase, New York 10577. The address of the principal office of each of Management IX, AIF IX LLC, Apollo LP, Management GP, and Management Holdings GP is 9 West 57th Street, New York, NY 10019. </TD></TR></TABLE>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Material Relationships with Selling Stockholders </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Apollo </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Apollo Global Management, Inc.
(&#147;Apollo&#148; and, together with its affiliates (including the Selling Stockholders), the &#147;Apollo Entities&#148;) is an affiliate of the Company. After giving effect to the resale of shares by the Selling Stockholders in the secondary
offering completed on April 2, 2024, including our repurchase of 500,000 shares as part of such offering, but without giving effect to this offering or to the Concurrent Share Repurchase, as of April 2, 2024, the Apollo Entities beneficially owned
approximately 6.1% of outstanding shares of our common stock, and, after giving effect to this offering and the Concurrent Share Repurchase, the Apollo Entities will cease to own any shares of our common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Apollo Entities acquired these shares from us in connection with our acquisition of Tiger Parent, the indirect parent entity of Tech Data.
Such shares of common stock were sold and issued by us to the Apollo Entities pursuant to the terms and subject to the conditions of the Merger Agreement. Additionally, in connection with the completion of the Mergers, we entered into an Investor
Rights Agreement (the &#147;Investor Rights Agreement&#148;) with Tiger Parent Holdings, L.P., an affiliate of Apollo. Pursuant to the Investor Rights Agreement, the Apollo Entities have the right to nominate (i)&nbsp;up to four directors if the
Apollo Entities own 30% or more of the outstanding shares of our common stock, (ii)&nbsp;up to three directors if the Apollo Entities own between 20% and 30% of the outstanding shares of our common stock, (iii)&nbsp;up to two directors, if the
Apollo Entities own between 10% and 20% of the outstanding shares of our common stock or (iv)&nbsp;up to one director, if the Apollo Entities own between 5% and 10% of the outstanding shares of our common stock (such directors nominated by the
Apollo Entities, the &#147;Apollo Directors&#148;). The current Apollo Directors are Robert Kalsow-Ramos, Nayaki Nayyar, and Matthew Nord. The Investor Rights Agreement also provides that, of the remaining directors who are not Apollo Directors, one
director shall be the then-serving Chief Executive Officer of the Company, currently Richard Hume, and the other directors will be nominated in accordance with the provisions of our bylaws and Certificate of Incorporation. The Apollo Directors must
fulfill their pro rata portion of any diversity requirements pursuant to law, stock exchange rules, or other regulatory requirements based on the percentage of our board of directors consisting of Apollo Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Investor Rights Agreement, we have waived the corporate opportunity doctrine to the extent permitted under the Delaware General
Corporation Law with respect to the Apollo Directors and Apollo Entities, so long as such person is not an employee of the Company or our subsidiaries (the &#147;Covered Persons&#148;). Specifically, we agreed that the Covered Persons do not have a
duty to refrain from: (i)&nbsp;investing in or conducting any business of any kind, (ii)&nbsp;doing business with our or any of our affiliates&#146; clients, customers, vendors or lessors, or (iii)&nbsp;making any investments in any kind of property
in which we may make investments. Further, we agreed, among other things, subject to any express agreement otherwise that may from time to time be in effect, that if a Covered Person acquires knowledge of a potential transaction which may constitute
a corporate opportunity for both (a)&nbsp;the Covered Person outside of his or her capacity as a member of our board of directors and (b)&nbsp;the Company, then the Covered Person shall not have any duty to offer or communicate information regarding
such corporate opportunity to us, and we renounced any interest or expectancy in any potential transaction or matter of which the Covered Person acquires knowledge, except for any corporate opportunity which is expressly offered to a Covered Person
in writing solely in his or her capacity as a member of our board of directors, or as expressly agreed otherwise. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, we granted the Apollo Entities certain registration rights pursuant to the
Investor Rights Agreement. Subject to several exceptions, including our right to defer a demand registration, underwritten shelf registration or <FONT STYLE="white-space:nowrap">non-underwritten</FONT> shelf registration under certain circumstances,
the Apollo Entities have the right to require us to register the sale of the shares of common stock held by them on Form <FONT STYLE="white-space:nowrap">S-3,</FONT> subject to offering size and other restrictions. The Apollo Entities also have the
right to request marketed and <FONT STYLE="white-space:nowrap">non-marketed</FONT> underwritten offerings using a shelf registration statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we propose to file certain types of registration statements under the Securities Act with respect to an offering of shares of common stock
(including for sale by us or at the request of any holder of registration rights), then we will be required to offer the Apollo Entities the opportunity to register any number of shares of common stock that they request, on the terms and conditions
set forth in the Investor Rights Agreement (customarily known as &#147;piggyback rights&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The registration rights granted under the
Investor Rights Agreement are subject to customary restrictions including, if a registration is underwritten, any limitations on the number of shares to be included in the underwritten offering as reasonably advised by the managing underwriters.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All expenses of registration under the Investor Rights Agreement, including the legal fees of counsel chosen by the Apollo Entities, but
excluding all applicable underwriting fees, discounts and similar charges, will be paid by us. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any sales in the public market of any
shares of common stock registrable pursuant to the registration rights granted under the Investor Rights Agreement could depress the market price of our shares of common stock. See &#147;Risk Factors&#151;Sales or the availability for sale of a
substantial number of shares of our common stock in the public market could cause our stock price to be volatile or fall.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Investor Rights Agreement also contains customary indemnification and contribution provisions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This offering is being made pursuant to
the registration rights granted under the Investor Rights Agreement. Our director Robert Kalsow-Ramos is a Partner, Private Equity at Apollo and our director Matthew Nord is a Partner and <FONT STYLE="white-space:nowrap">Co-Head</FONT> of Private
Equity at Apollo. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For more information on these relationships, please refer to the 2023 Annual Report (as defined below), which is
incorporated herein by reference. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We intend to purchase from the underwriters 1,750,000 shares of our common stock offered in this
offering, at a price per share equal to the price per share to be paid by the underwriters to the Selling Stockholders, as part of our existing stock repurchase program. See &#147;Concurrent Share Repurchase.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="s776938_9"></A>MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES TO <FONT
STYLE="white-space:nowrap">NON-U.S.</FONT> HOLDERS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a general discussion of the material U.S. federal income tax
considerations applicable to <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holders (as defined herein) with respect to their ownership and disposition of shares of our common stock sold pursuant to this offering. This discussion does not address
all aspects of U.S. federal income tax considerations relating thereto. This discussion also does not address the tax considerations arising under the laws of any <FONT STYLE="white-space:nowrap">non-U.S.,</FONT> state, or local jurisdiction, nor
under U.S. federal gift and estate tax laws, except to the limited extent provided below. For the purposes of this discussion, a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder means a beneficial owner of our common stock (other than a
partnership or an entity or arrangement treated as a partnership for U.S. federal income tax purposes) that is not, for U.S. federal income tax purposes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an individual who is a citizen or resident of the United States; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a corporation, or an entity treated as a corporation for U.S. federal income tax purposes, created or organized
in the United States or under the laws of the United States or of any state thereof or the District of Columbia; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an estate, the income of which is subject to U.S. federal income tax regardless of its source; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a trust if (1)&nbsp;a U.S. court can exercise primary supervision over the trust&#146;s administration and one or
more U.S. persons have the authority to control all of the trust&#146;s substantial decisions or (2)&nbsp;the trust has a valid election in effect under applicable U.S. Treasury Regulations to be treated as a U.S. person. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This discussion is based on current provisions of the U.S. Internal Revenue Code of 1986, as amended (the &#147;Code&#148;), existing U.S.
Treasury Regulations promulgated thereunder, published administrative pronouncements and rulings of the U.S. Internal Revenue Service (&#147;IRS&#148;), and judicial decisions, all as in effect as of the date of this prospectus supplement. These
authorities are subject to change and to differing interpretation, possibly with retroactive effect. Any change or differing interpretation could alter the tax consequences to <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holders described in
this prospectus supplement and the accompanying prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We assume in this discussion that a
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder holds shares of our common stock as a capital asset within the meaning of Section&nbsp;1221 of the Code (generally, for investment). This discussion does not address all aspects of U.S. federal
income taxation that may be relevant to a particular <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder in light of that <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s individual circumstances, nor does it address any estate or
gift tax consequences, except to the limited extent provided below, or any aspects of U.S. state, local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> taxes. This discussion also does not consider any specific facts or circumstances that may
apply to a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder and does not address the special tax rules applicable to particular <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holders, such as holders that own, or are deemed to own, more
than 5% of our capital stock (except to the extent specifically set forth below), corporations that accumulate earnings to avoid U.S. federal income tax, <FONT STYLE="white-space:nowrap">tax-exempt</FONT> organizations, banks, financial
institutions, insurance companies, brokers, dealers or traders in securities, commodities or currencies, <FONT STYLE="white-space:nowrap">tax-qualified</FONT> retirement plans, accrual method taxpayers subject to special tax accounting rules under
Section&nbsp;451(b) of the Code, holders subject to the alternative minimum tax or the Medicare contribution tax, holders holding our common stock as part of a hedge, straddle or other risk reduction strategy, conversion transaction or other
integrated investment, holders deemed to sell our common stock under the constructive sale provisions of the Code, controlled foreign corporations, passive foreign investment companies and certain former U.S. citizens or long-term residents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, this discussion does not address the tax treatment of partnerships (or entities or arrangements that are treated as partnerships
for U.S. federal income tax purposes) or persons that hold their common stock through such partnerships. If a partnership, including any entity or arrangement treated as a partnership for U.S. federal income tax purposes, holds shares of our common
stock, the U.S. federal income tax treatment of a partner in such partnership will generally depend upon the status of the partner and the activities of the partnership. Such partners and partnerships should consult their own tax advisors regarding
the tax consequences of the purchase, ownership, and disposition of our common stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There can be no assurance that a court or the IRS will not challenge one or more of the tax
consequences described herein, and we have not obtained, nor do we intend to obtain, an IRS ruling with respect to the U.S. federal income tax consequences to a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder of the purchase, ownership or
disposition of our common stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Distributions on Our Common Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Distributions, if any, on our common stock generally will constitute dividends for U.S. federal income tax purposes to the extent paid from our
current or accumulated earnings and profits, as determined under U.S. federal income tax principles. If a distribution exceeds our current and accumulated earnings and profits, the excess will be treated as a
<FONT STYLE="white-space:nowrap">tax-free</FONT> return of the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s investment, up to such holder&#146;s adjusted tax basis in the common stock. Any remaining excess will be treated as
capital gain from the sale or exchange of such common stock, subject to the tax treatment described below in &#147;Gain on Sale, Exchange, or Other Disposition of Our Common Stock.&#148; Any such distribution will also be subject to the tax
treatment described below under the heading &#147;FATCA Withholding.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Dividends paid to a
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder will generally be subject to withholding of U.S. federal income tax at a 30% rate or such lower rate as may be specified by an applicable income tax treaty between the United States and such
holder&#146;s country of residence. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Dividends that are treated as effectively connected with a trade or business conducted by a <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> holder within the United States and, if an applicable income tax treaty so provides, that are attributable to a permanent establishment or a fixed base maintained by the
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder within the United States, are generally exempt from the 30% withholding tax if the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder satisfies applicable certification and disclosure
requirements. However, such U.S. effectively connected income, net of specified deductions and credits, is taxed at the same graduated U.S. federal income tax rates applicable to U.S. persons (as defined in the Code). Any U.S. effectively connected
income received by a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder that is a corporation may also, under certain circumstances, be subject to an additional &#147;branch profits tax&#148; at a 30% rate or such lower rate as may be specified
by an applicable income tax treaty between the United States and such holder&#146;s country of residence. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To claim a reduction or
exemption from withholding, a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder of our common stock generally will be required to provide (a)&nbsp;a properly executed IRS Form <FONT STYLE="white-space:nowrap">W-8BEN</FONT> or <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">W-8BEN-E</FONT></FONT> (or successor form) and satisfy applicable certification and other requirements to claim the benefit of an applicable income tax treaty between the United States and
such holder&#146;s country of residence or (b)&nbsp;a properly executed IRS Form <FONT STYLE="white-space:nowrap">W-8ECI</FONT> stating that the dividends are not subject to withholding because they are effectively connected with such <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s conduct of a trade or business within the United States. <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holders are urged to consult their tax advisors regarding their entitlement to
benefits under a relevant income tax treaty. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder that is eligible for a reduced
rate of U.S. withholding tax under an income tax treaty may obtain a refund or credit of any excess amounts withheld by timely filing an appropriate claim for refund with the IRS. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Gain on Sale, Exchange, or Other Disposition of Our Common Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the discussion below regarding backup withholding and FATCA, in general, a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder
will not be subject to any U.S. federal income tax on any gain realized upon such holder&#146;s sale, exchange or other disposition of shares of our common stock unless: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the gain is effectively connected with a U.S. trade or business of
<FONT STYLE="white-space:nowrap">the&nbsp;non-U.S.&nbsp;holder</FONT> and, if an applicable income tax treaty so provides, is attributable to a permanent establishment or a fixed base maintained in the United States by
<FONT STYLE="white-space:nowrap">such&nbsp;non-U.S.&nbsp;holder,</FONT> in which case <FONT STYLE="white-space:nowrap">the&nbsp;non-U.S.&nbsp;holder</FONT> generally will be taxed at the graduated U.S. federal income tax rates applicable to U.S.
persons (as defined in </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
the Code) (or such lower rate as may be specified by an applicable income tax treaty) and, if <FONT STYLE="white-space:nowrap">the&nbsp;non-U.S.&nbsp;holder</FONT> is a foreign corporation, the
branch profits tax described above in &#147;Distributions on Our Common Stock&#148; also may apply; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder is a nonresident alien individual who is present in
the United States for 183 days or more in the taxable year of the disposition and certain other conditions are met, in which case the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder will be subject to a 30% tax (or such lower rate as may be
specified by an applicable income tax treaty) on the net gain derived from the disposition, which may be offset by U.S. source capital losses of the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder, if any (even though the individual is not
considered a resident of the United States); or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our common stock constitutes a U.S. real property interest because we are, or have been, at any time during the
five-year period preceding such disposition (or <FONT STYLE="white-space:nowrap">the&nbsp;non-U.S.&nbsp;holder&#146;s</FONT> holding period, if shorter) a &#147;United States real property holding corporation.&#148; Generally, a corporation is a
United States real property holding corporation only if the fair market value of its U.S. real property interests (as defined in the Code and applicable U.S. Treasury Regulations) equals or exceeds 50% of the sum of the fair market value of its
worldwide real property interests plus its other assets used or held for use in a trade or business. Although there can be no assurance, we do not believe that we are, or have been, a United States real property holding corporation, or that we are
likely to become one in the future. Even if we are or become a United States real property holding corporation, provided that our common stock is regularly traded on an established securities market, within the meaning of applicable Treasury
Regulations, our common stock will be treated as a U.S. real property interest only with respect to <FONT STYLE="white-space:nowrap">a&nbsp;non-U.S.&nbsp;holder</FONT> that holds more than 5% of our outstanding common stock, directly or indirectly,
actually or constructively, during the shorter of <FONT STYLE="white-space:nowrap">the&nbsp;5-year&nbsp;period</FONT> ending on the date of the disposition or the period that <FONT STYLE="white-space:nowrap">the&nbsp;non-U.S.&nbsp;holder</FONT> held
our common stock. In such case, <FONT STYLE="white-space:nowrap">such&nbsp;non-U.S.&nbsp;holder</FONT> generally will be taxed on its net gain derived from the disposition at the graduated U.S. federal income tax rates applicable to U.S. persons (as
defined in the Code). Regardless of whether our common stock is currently treated as being regularly traded on an established securities market within the meaning of the applicable U.S. Treasury Regulations, no assurance can be provided that our
common stock will continue to be regularly traded on an established securities market for purposes of the rules described above. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>U.S. Federal Estate Tax </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The estates of
nonresident alien individuals generally are subject to U.S. federal estate tax on property with a U.S. situs. Because we are a U.S. corporation, our common stock will be U.S. situs property and therefore will be included in the taxable estate of a
nonresident alien decedent, unless an applicable estate tax treaty between the United States and the decedent&#146;s country of residence provides otherwise. Investors are urged to consult their own tax advisors regarding the U.S. federal estate tax
consequences of the ownership or disposition of our common stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Information Reporting and Backup Withholding </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We generally must report annually to the IRS and to each <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder the gross amount of
distributions on our common stock paid to such holder, whether or not such distribution is a dividend for U.S. federal income tax purposes, and the tax withheld, if any, with respect to such distributions.
<FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holders will have to comply with specific certification procedures to establish that the holder is not a U.S. person (as defined in the Code) in order to avoid backup withholding at the applicable
rate with respect to dividends on our common stock. A <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder generally will not be subject to U.S. backup withholding with respect to payments of dividends on our common stock if it certifies its <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> status by providing a valid IRS Form <FONT STYLE="white-space:nowrap">W-8BEN,</FONT> <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">W-8BEN-E</FONT></FONT> or <FONT
STYLE="white-space:nowrap">W-8ECI</FONT> (or successor form), or otherwise establishes an exemption; provided we do not have actual knowledge or reason to know such <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder is a U.S. person, as defined
in the Code. Dividends paid to <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holders subject to the U.S. withholding tax, as described above in &#147;Distributions on Our Common Stock,&#148; generally will be exempt from U.S. backup withholding.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Information reporting and backup withholding will generally apply to the proceeds of a
disposition of our common stock by a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder effected by or through the U.S. office of any broker, U.S. or foreign, unless the holder certifies its status as a
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder and satisfies certain other requirements, or otherwise establishes an exemption. Generally, information reporting and backup withholding will not apply to a payment of disposition proceeds to a
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder where the transaction is effected outside the United States through a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> office of a broker. However, information reporting but not backup
withholding will apply in a manner similar to dispositions effected through a U.S. office of a broker, if a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder sells our common stock through a <FONT STYLE="white-space:nowrap">non-U.S.</FONT>
office of a broker that is: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a U.S. person (including a foreign branch or office of such person), </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a &#147;controlled foreign corporation&#148; for U.S. federal income tax purposes, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a foreign person 50% or more of whose gross income from certain periods is effectively connected with a U.S.
trade or business, or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a foreign partnership if at any time during its tax year (a)&nbsp;one or more of its partners are U.S. persons
who, in the aggregate, hold more than 50% of the income or capital interests of the partnership or (b)&nbsp;the foreign partnership is engaged in a U.S. trade or business. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holders should consult their own tax advisors regarding the application of the information
reporting and backup withholding rules to them. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Copies of information returns may be made available to the tax authorities of the country
in which the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder resides or is incorporated under the provisions of a specific treaty or agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules from a payment to a <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> holder may be allowed as a credit against the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s U.S. federal income tax liability, if any, and may entitle such holder to a refund, provided that
the required information is timely furnished to the IRS. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>FATCA Withholding </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Code, U.S. Treasury Regulations and other applicable guidance, commonly referred to as &#147;FATCA,&#148; generally impose a U.S. federal
withholding tax of 30% on dividends on stock in a U.S. corporation paid to (i)&nbsp;a &#147;foreign financial institution&#148; (as specifically defined for this purpose), unless such institution enters into an agreement with the U.S. government to,
among other things, withhold on certain payments and to collect and provide to the U.S. tax authorities substantial information regarding U.S. account holders of such institution (which includes certain equity and debt holders of such institution,
as well as certain account holders that are foreign entities with U.S. owners) or otherwise qualifies for an exemption from these rules and (ii)&nbsp;a <FONT STYLE="white-space:nowrap">&#147;non-financial</FONT> foreign entity&#148; (as defined in
the Code), unless such entity provides the withholding agent with either a certification that it does not have any substantial direct or indirect U.S. owners or provides information regarding substantial direct and indirect U.S. owners of the
entity, or otherwise qualifies for an exemption from these rules. U.S. Treasury Regulations proposed in December 2018 (and upon which taxpayers and withholding agents are entitled to rely) eliminate possible FATCA withholding on the gross proceeds
from any sale or other disposition of shares of stock of a U.S. corporation, previously scheduled to apply beginning January&nbsp;1, 2019. Under certain circumstances, a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder might be eligible for
refunds or credits of such taxes. An intergovernmental agreement between the United States and an applicable foreign country may modify the requirements described in this paragraph. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">EACH PROSPECTIVE INVESTOR SHOULD CONSULT ITS OWN TAX ADVISOR REGARDING THE PARTICULAR U.S. FEDERAL, STATE AND LOCAL AND <FONT
STYLE="white-space:nowrap">NON-U.S.</FONT> TAX CONSEQUENCES OF THE PURCHASE, OWNERSHIP AND DISPOSITION OF OUR COMMON STOCK, INCLUDING THE CONSEQUENCES OF ANY PROPOSED CHANGE IN APPLICABLE LAWS. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="s776938_10"></A>UNDERWRITING (CONFLICT OF INTEREST) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We, the Selling Stockholders and the underwriters named below have entered into an underwriting agreement with respect to the shares being
offered. Subject to certain conditions, each underwriter has severally agreed to purchase the number of shares indicated in the following table, which includes the shares subject to the Concurrent Share Repurchase, see &#147;Concurrent Share
Repurchase.&#148; J.P. Morgan Securities LLC, Citigroup Global Markets Inc., Goldman Sachs &amp; Co. LLC, Mizuho Securities USA LLC, and RBC Capital Markets, LLC are the representatives of the underwriters. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Underwriters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Number&nbsp;of&nbsp;Shares</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,256,455</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Citigroup Global Markets Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">763,211</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goldman Sachs &amp; Co. LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">763,211</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mizuho Securities USA LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">763,211</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RBC Capital Markets, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">763,211</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,309,299</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriters are committed to take and pay for all of the shares being offered, if any are taken. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We intend to purchase from the underwriters 1,750,000 shares of our common stock offered in this offering, at a price per share equal to the
price per share to be paid by the underwriters to the Selling Stockholders, as part of our existing stock repurchase program. See &#147;Concurrent Share Repurchase.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriters have agreed to purchase the shares of common stock from the Selling Stockholders at a price of $114.20 per share, which will
result in approximately $606,321,946 of proceeds to the Selling Stockholders before expenses. The underwriters propose to offer the shares of common stock, other than shares subject to the Concurrent Share Repurchase, from time to time for sale in
one or more transactions on the NYSE, in the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market, through negotiated transactions or otherwise at market prices prevailing at the time of sale, at
prices related to prevailing market prices or at negotiated prices, subject to receipt and acceptance by them and subject to their right to reject any order in whole or in part. In connection with the sale of the shares of common stock offered
hereby, the underwriters may be deemed to have received compensation in the form of underwriting discounts. The underwriters may effect such transactions by selling shares of common stock to or through dealers, and such dealers may receive
compensation in the form of discounts, concessions or commissions from the underwriters and / or purchasers of shares of common stock for whom they may act as agents or to whom they may sell as principal. The underwriters will not receive any
compensation for the shares being repurchased by us pursuant to the Concurrent Share Repurchase. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have agreed with the underwriters,
subject to certain exceptions, not to dispose of any of our common stock or securities convertible into or exchangeable for shares of common stock during the period from the date of this prospectus supplement continuing through the date 30&nbsp;days
after the date of this prospectus supplement, except with the prior written consent of J.P. Morgan Securities LLC. In addition, in connection with a prior offering of shares by the Selling Stockholders that closed on April&nbsp;2, 2024, the Selling
Stockholders and all of our executive officers and directors agreed, subject to certain exceptions described below, not to dispose of or hedge any of their common stock or securities convertible into or exchangeable for shares of common stock
through April&nbsp;26, 2024, except with the prior written consent of J.P. Morgan Securities LLC. J.P. Morgan Securities LLC has provided a waiver with respect to those lock-up agreements signed by the Selling Stockholders to permit the Selling
Stockholders to sell the 5,309,299 shares of common stock offered hereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement
applicable to us is subject to certain specified exceptions, including: (i)&nbsp;any issuance of common stock, options to purchase shares of common stock, restricted stock units and any other equity incentive compensation issued pursuant to employee
benefit plans, qualified stock option plans or other </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
employee compensation plans described in this prospectus supplement; (ii)&nbsp;common stock issued upon exercise of outstanding options, warrants or rights, whether or not issued under one of
those plans, and common stock issued upon the exercise of options or the settlement of restricted stock units granted under such plans or under equity plans or similar plans of companies acquired by us in effect on the date of acquisition; and
(iii)&nbsp;any issuance of common stock upon the conversion or exchange of convertible or exchangeable securities outstanding as of the date of this prospectus supplement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements applicable to the Selling Stockholders and all of our directors and executive
officers that were entered into in connection with the prior offering of shares by the Selling Stockholders that closed on April&nbsp;2, 2024 are subject to specified exceptions, including: (i)&nbsp;bona fide gifts; (ii)&nbsp;transfers to any trust
for the direct or indirect benefit of the <FONT STYLE="white-space:nowrap">lock-up</FONT> party or the immediate family of the <FONT STYLE="white-space:nowrap">lock-up</FONT> party; (iii)&nbsp;transfers by will or intestacy; (iv)&nbsp;transfers to a
partnership, limited liability company or other entity in which the <FONT STYLE="white-space:nowrap">lock-up</FONT> party and the immediate family of the <FONT STYLE="white-space:nowrap">lock-up</FONT> party are the legal and beneficial owner of all
the outstanding equity securities or similar interests; (v)&nbsp;transfers by operation of law, such as pursuant to a qualified domestic order or in connection with a divorce settlement; (vi)&nbsp;open market transactions after the completion of
this offering or transfers to the underwriters in this offering; (vii)&nbsp;(A) the exercise of stock options solely with cash granted pursuant to equity incentive plans described in this prospectus supplement, and the receipt by the <FONT
STYLE="white-space:nowrap">lock-up</FONT> party from us of shares of common stock upon such exercise; (B)&nbsp;transfers to us upon the &#147;net&#148; or &#147;cashless&#148; exercise of stock options or other equity awards granted pursuant to
equity incentive plans; (C)&nbsp;transfers for the primary purpose of satisfying any tax or other governmental withholding obligation with respect to any award of equity-based compensation granted pursuant to our equity incentive plans described in
this prospectus supplement; or (D)&nbsp;forfeitures to us to satisfy tax withholding requirements of the <FONT STYLE="white-space:nowrap">lock-up</FONT> party or us upon the vesting, during the restricted period, of equity-based awards granted under
equity incentive plans or pursuant to other stock purchase arrangements, in each cased described in this prospectus supplement; (viii)&nbsp;a bona fide third-party tender offer, merger, consolidation or other similar transaction made to all holders
of our capital stock; (ix)&nbsp;transfers to us in connection with the repurchase by us of shares of common stock or other securities pursuant to a repurchase right arising upon the termination of a <FONT STYLE="white-space:nowrap">lock-up</FONT>
party&#146;s employment with us; (x)&nbsp;(A) the establishment of a trading plan pursuant to Rule <FONT STYLE="white-space:nowrap">10b5-1</FONT> of the Exchange Act; or (B)&nbsp;transfers pursuant to an existing
<FONT STYLE="white-space:nowrap">10b5-1</FONT> trading plan, provided that no such transfers shall be made prior to the closing date of this offering; (xi)&nbsp;if the <FONT STYLE="white-space:nowrap">lock-up</FONT> party is a corporation,
partnership, limited liability company or other business entity, (A)&nbsp;distributions to limited and general partners, members, stockholders or holders of similar interests or (B)&nbsp;transfers to affiliates (as defined in Rule 405 of the
Securities Act); (xii) the pledge of shares of common stock as collateral or security pursuant to the Margin Loan Agreements dated as of March&nbsp;3, 2022 among entities affiliated with Apollo, the lenders party thereto and Barclays Bank plc, and
any refinancing or other modification of such margin loan financing or any transfer upon foreclosure or thereafter upon such shares; or (xiii)&nbsp;transfers to the <FONT STYLE="white-space:nowrap">lock-up</FONT> party&#146;s employer or any
affiliate of the <FONT STYLE="white-space:nowrap">lock-up</FONT> party&#146;s employer as compensation in his or her capacity as a member of our board of directors; provided that, in the case of any transfer or distribution pursuant to
(i)&nbsp;through (v), (vii), (xi) and (xiii), the transferee or distributee agrees in writing to be bound by the <FONT STYLE="white-space:nowrap">lock-up</FONT> restrictions. One of our executive officers was granted an exemption allowing the sale
of up to 20,000 shares of common stock (representing 0.02% of the common stock outstanding as of February&nbsp;29, 2024) after April&nbsp;6, 2024. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Shares of our common stock are listed on the NYSE under the symbol &#147;SNX.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with this offering, the underwriters may purchase and sell shares of common stock in the open market. These transactions may
include short sales, stabilizing transactions and purchases to cover positions created by short sales. Short sales involve the sale by the underwriters of a greater number of shares than they are required to purchase in this offering, and a short
position represents the amount of such sales that have not been covered by subsequent purchases. As the underwriters do not have an option to purchase additional shares from the Selling Stockholders in this offering, any short sales by the
underwriters would be &#147;naked&#148; short sales. The underwriters must cover any such naked short position by purchasing shares in the open market. A naked short position is more likely to be created if the underwriters are concerned that there
may be downward pressure on </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the price of the common stock in the open market after pricing that could adversely affect investors who purchase in this offering. Stabilizing transactions consist of various bids for or
purchases of common stock made by the underwriters in the open market prior to the completion of this offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriters may also
impose a penalty bid. This occurs when a particular underwriter repays to the underwriters a portion of the underwriting discount received by it because the representatives have repurchased shares sold by or for the account of such underwriter in
stabilizing or short covering transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Purchases to cover a short position and stabilizing transactions, as well as other purchases
by the underwriters for their own accounts, may have the effect of preventing or retarding a decline in the market price of our stock, and together with the imposition of the penalty bid, may stabilize, maintain or otherwise affect the market price
of our common stock. As a result, the price of our common stock may be higher than the price that otherwise might exist in the open market. The underwriters are not required to engage in these activities and may end any of these activities at any
time. These transactions may be effected on the NYSE, in the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market or otherwise. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Conflict of Interest </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Apollo Global Securities, LLC (&#147;AGS&#148;) has a &#147;conflict of interest&#148; within the meaning of FINRA Rule 5121 in this offering
because AGS is affiliated with the Selling Stockholders, who are in turn one of our affiliates, and because the net proceeds of this offering will be received by the Selling Stockholders. Accordingly, this offering will be conducted in accordance
with the requirements of Financial Industry Regulation Authority (&#147;FINRA&#148;) Rule 5121 regarding a FINRA member firm&#146;s participation in a public offering of securities of an affiliate. Pursuant to that rule, the appointment of a
&#147;qualified independent underwriter&#148; is not required in connection with this offering. In accordance with FINRA Rule 5121, neither AGS nor any other affiliated underwriter, agent or dealer may sell the securities to any account over which
it exercises discretionary authority without the specific written approval of the account holder. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Other Relationships </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriters and their respective affiliates are full service financial institutions engaged in various activities, which may include sales
and trading, commercial and investment banking, advisory, investment management, investment research, principal investment, hedging, market making, brokerage and other financial and <FONT STYLE="white-space:nowrap">non-financial</FONT> activities
and services. Certain of the underwriters and their respective affiliates have provided, and may in the future provide, a variety of these services to us and Apollo and to persons and entities with relationships with us or Apollo, for which they
received or will receive customary fees and expenses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the ordinary course of their various business activities, the underwriters and
their respective affiliates, officers, directors and employees may purchase, sell or hold a broad array of investments and actively traded securities, derivatives, loans, commodities, currencies, credit default swaps and other financial instruments
for their own account and for the accounts of their customers, and such investment and trading activities may involve or relate to assets, securities and/or instruments of us and Apollo (directly, as collateral securing other obligations or
otherwise) and/or persons and entities with relationships with us or Apollo. The underwriters and their respective affiliates may also communicate independent investment recommendations, market color or trading ideas and/or publish or express
independent research views in respect of such assets, securities or instruments and may at any time hold, or recommend to clients that they should acquire, long and/or short positions in such assets, securities and instruments. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Selling Restrictions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>European Economic Area </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
relation to each Member State of the European Economic Area (each a &#147;Relevant State&#148;), no shares have been offered or will be offered pursuant to the offering to the public in that Relevant State prior to the publication
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of a prospectus in relation to the shares which has been approved by the competent authority in that Relevant State or, where appropriate, approved in another Relevant State and notified to the
competent authority in that Relevant State, all in accordance with the Prospectus Regulation, except that it may make an offer to the public in that Relevant State of any shares at any time under the following exemptions under the Prospectus
Regulation: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to any legal entity which is a qualified investor as defined under the Prospectus Regulation;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to fewer than 150 natural or legal persons (other than qualified investors as defined under the Prospectus
Regulation), subject to obtaining the prior consent of the representative for any such offer; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in any other circumstances falling within Article 1(4) of the Prospectus Regulation; </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">provided that no such offer of shares shall require us or any representative to publish a prospectus pursuant to Article 3 of the Prospectus Regulation or
supplement a prospectus pursuant to Article 23 of the Prospectus Regulation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the purposes of this provision, the expression an
&#147;offer to the public&#148; in relation to shares in any Relevant State means the communication in any form and by any means of sufficient information on the terms of the offer and any shares to be offered so as to enable an investor to decide
to purchase or subscribe for any shares, and the expression &#147;Prospectus Regulation&#148; means Regulation (EU) 2017/1129. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>United
Kingdom </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In relation to the United Kingdom, no shares have been offered or will be offered pursuant to the offering to the public in
the United Kingdom prior to the publication of a prospectus in relation to the shares that either has been approved by the Financial Conduct Authority, or (ii)&nbsp;is to be treated as if it had been approved by the Financial Conduct Authority in
accordance with the transitional provision in Regulation 74 of the Prospectus (Amendment etc.) (EU Exit) Regulations 2019, except that offers of shares may be made to the public in the United Kingdom at any time under the following exemptions under
the UK Prospectus Regulation: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to any legal entity which is a qualified investor as defined under Article 2 of the UK Prospectus Regulation;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to fewer than 150 natural or legal persons (other than qualified investors as defined under Article 2 of the UK
Prospectus Regulation), subject to obtaining the prior consent of representative for any such offer; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in any other circumstances falling within Section&nbsp;86 of the Financial Services and Markets Act 2000 (the
&#147;FSMA&#148;); provided that no such offer of shares shall require us or any representative to publish a prospectus pursuant to Section&nbsp;85 of the FSMA or supplement a prospectus pursuant to Article 23 of the UK Prospectus Regulation.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the purposes of this provision, the expression an &#147;offer to the public&#148; in relation to the shares in the
United Kingdom means the communication in any form and by any means of sufficient information on the terms of the offer and any shares to be offered so as to enable an investor to decide to purchase or subscribe for any shares and the expression
&#147;UK Prospectus Regulation&#148; means Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, this prospectus is only being distributed to, and is only directed at, and any investment or investment activity to which this
prospectus relates is available only to, and will be engaged in only with, persons who are outside the United Kingdom or persons in the United Kingdom (i)&nbsp;having professional experience in matters relating to investments who fall within the
definition of &#147;investment professionals&#148; in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the &#147;Order&#148;); or (ii)&nbsp;who are high net worth entities falling within Article 49(2)(a)
to (d)&nbsp;of the Order (all such persons together being referred to as &#147;relevant persons&#148;). Persons who are not relevant persons should not take any action on the basis of this prospectus and should not act or rely on it. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Canada </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares may be sold in Canada only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as
defined in National Instrument <FONT STYLE="white-space:nowrap">45-106</FONT> Prospectus Exemptions or subsection 73.3(1) of the Securities Act (Ontario), and are permitted clients, as defined in National Instrument
<FONT STYLE="white-space:nowrap">31-103</FONT> Registration Requirements, Exemptions, and Ongoing Registrant Obligations. Any resale of the shares must be made in accordance with an exemption from, or in a transaction not subject to, the prospectus
requirements of applicable securities laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Securities legislation in certain provinces or territories of Canada may provide a purchaser
with remedies for rescission or damages if this prospectus supplement or accompanying prospectus (including any amendment thereto) contains a misrepresentation, provided that the remedies for rescission or damages are exercised by the purchaser
within the time limit prescribed by the securities legislation of the purchaser&#146;s province or territory. The purchaser should refer to any applicable provisions of the securities legislation of the purchaser&#146;s province or territory of
these rights or consult with a legal advisor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to section 3A.3 of National Instrument
<FONT STYLE="white-space:nowrap">33-105</FONT> Underwriting Conflicts (NI <FONT STYLE="white-space:nowrap">33-105),</FONT> the underwriters are not required to comply with the disclosure requirements of NI
<FONT STYLE="white-space:nowrap">33-105</FONT> regarding underwriter conflicts of interest in connection with this offering. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Hong Kong
</I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares have not been offered or sold and will not be offered or sold in Hong Kong, by means of any document, other than
(a)&nbsp;to &#147;professional investors&#148; as defined in the Securities and Futures Ordinance (Cap. 571) of Hong Kong and any rules made under that Ordinance; or (b)&nbsp;in other circumstances which do not result in the document being a
&#147;prospectus&#148; as defined in the Companies Ordinance (Cap. 32) of Hong Kong or which do not constitute an offer to the public within the meaning of that Ordinance. No advertisement, invitation or document relating to the shares has been or
may be issued or has been or may be in the possession of any person for the purpose of issue, whether in Hong Kong or elsewhere, which is directed at, or the contents of which are likely to be accessed or read by, the public of Hong Kong (except if
permitted to do so under the securities laws of Hong Kong) other than with respect to shares which are or are intended to be disposed of only to persons outside Hong Kong or only to &#147;professional investors&#148; as defined in the Securities and
Futures Ordinance and any rules made under that Ordinance. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Singapore </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus has not been registered as a prospectus with the Monetary Authority of Singapore. Accordingly, this prospectus and any other
document or material in connection with the offer or sale, or invitation for subscription or purchase, of the shares may not be circulated or distributed, nor may the shares be offered or sold, or be made the subject of an invitation for
subscription or purchase, whether directly or indirectly, to persons in Singapore other than (i)&nbsp;to an institutional investor under Section&nbsp;274 of the Securities and Futures Act, Chapter 289 of Singapore, or the SFA, (ii)&nbsp;to a
relevant person pursuant to Section&nbsp;275(1), or any person pursuant to Section&nbsp;275(1A), and in accordance with the conditions specified in Section&nbsp;275 of the SFA or (iii)&nbsp;otherwise pursuant to, and in accordance with the
conditions of, any other applicable provision of the SFA, in each case subject to compliance with conditions set forth in the SFA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Where
our shares are subscribed or purchased under Section&nbsp;275 by a relevant person which is: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a corporation (which is not an accredited investor (as defined in Section&nbsp;4A of the SFA)) the sole
business of which is to hold investments and the entire share capital of which is owned by one or more individuals, each of whom is an accredited investor; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a trust (where the trustee is not an accredited investor) whose sole purpose is to hold investments and each
beneficiary of the trust is an individual who is an accredited investor, </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">shares, debentures and units of shares and debentures of that corporation or the beneficiaries&#146; rights
and interest (howsoever described) in that trust shall not be transferred within six months after that corporation or that trust has acquired the shares pursuant to an offer made under Section&nbsp;275 of the SFA except: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to an institutional investor (for corporations, under Section&nbsp;274 of the SFA) or to a relevant person
defined in Section&nbsp;275(2) of the SFA, or to any person arising from an offer referred to in </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Section&nbsp;275(1A) or Section&nbsp;276(4)(i)(B) of the SFA; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">where no consideration is or will be given for the transfer; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">where the transfer is by operation of law; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">as specified in Section&nbsp;276(7) of the SFA; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">as specified in Regulation 32 of the Securities and Futures (Offers of Investments) (Shares and Debentures)
Regulations 2005 of Singapore. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Solely for the purposes of our obligations pursuant to Section&nbsp;309B of the SFA, we
have determined, and hereby notify all relevant persons (as defined in the CMP Regulations 2018), that our shares are &#147;prescribed capital markets products&#148; (as defined in the CMP Regulations 2018) and Excluded Investment Products (as
defined in MAS Notice SFA <FONT STYLE="white-space:nowrap">04-N12:</FONT> Notice on the Sale of Investment Products and MAS Notice <FONT STYLE="white-space:nowrap">FAA-N16:</FONT> Notice on Recommendations on Investment Products). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Japan </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our shares have
not been and will not be registered under the Financial Instruments and Exchange Law of Japan (Law No.&nbsp;25 of 1948, as amended) and, accordingly, will not be offered or sold, directly or indirectly, in Japan, or for the benefit of any Japanese
Person or to others for <FONT STYLE="white-space:nowrap">re-offering</FONT> or resale, directly or indirectly, in Japan or to any Japanese Person, except in compliance with all applicable laws, regulations and ministerial guidelines promulgated by
relevant Japanese governmental or regulatory authorities in effect at the relevant time. For the purposes of this paragraph, &#147;Japanese Person&#148; shall mean any person resident in Japan, including any corporation or other entity organized
under the laws of Japan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="s776938_11"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The validity of the shares of common stock being offered hereby will be passed upon for us by Pillsbury Winthrop Shaw Pittman LLP, Palo Alto,
California. Paul, Weiss, Rifkind, Wharton&nbsp;&amp; Garrison LLP, New York, New York, acted as counsel for the Selling Stockholders. Certain legal matters in connection with this offering will be passed upon for the underwriters by Davis
Polk&nbsp;&amp; Wardwell LLP, New York, New York. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="s776938_12"></A>EXPERTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The consolidated financial statements and financial statement schedule of TD SYNNEX Corporation and subsidiaries as of November&nbsp;30, 2023
and 2022, and for each of the years in the three-year period ended November&nbsp;30, 2023, and management&#146;s assessment of the effectiveness of internal control over financial reporting as of November&nbsp;30, 2023 have been incorporated by
reference herein and in the registration statement in reliance upon the report of KPMG LLP, independent registered public accounting firm, incorporated by reference herein, and upon the authority of said firm as experts in accounting and auditing.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="s776938_13"></A>WHERE YOU CAN FIND MORE INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have filed with the SEC a registration statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> under the Securities Act with respect
to the shares of common stock offered by this prospectus supplement. This prospectus supplement and the accompanying prospectus are part of the registration statement, but the registration statement includes and incorporates by reference additional
information and exhibits. This prospectus supplement does not contain all the information set forth in the registration statement and its exhibits and schedules, portions of which have been omitted as permitted by the rules and regulations of the
SEC. For further information about us, we refer you to the registration statement and to its exhibits and schedules. Certain information in the registration statement has been omitted from this prospectus supplement and the accompanying prospectus
in accordance with the rules of the SEC. Statements contained in this prospectus supplement and the accompanying prospectus regarding the contents of any agreement, contract or other document referred to are not necessarily complete; reference is
made in each instance to the copy of the contract or document filed as an exhibit to the registration statement. Each statement is qualified by reference to the exhibit. You may read and obtain a copy of the registration statement without charge at
the SEC&#146;s website. The SEC&#146;s website address is www.sec.gov. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are subject to the information requirements of the Securities
Exchange Act of 1934 (the &#147;Exchange Act&#148;). We file annual, quarterly, and current reports, proxy statements and other information with the SEC. The SEC maintains a website that contains reports, proxy and information statements and other
information regarding companies, such as ours, that file documents electronically with the SEC. The address of that site is www.sec.gov. You can obtain copies of this material without charge at the SEC&#146;s website noted above. We furnish our
stockholders with annual reports containing consolidated financial statements audited by our independent registered public accounting firm. You may also access the documents we file with the SEC on our website at www.tdsynnex.com. The information on
the SEC&#146;s website and on our website are not part of, and are not incorporated by reference into, this prospectus supplement or the accompanying prospectus, or the registration statement of which this prospectus supplement forms a part, any
references to these websites or any other website are inactive textual references only, and you should not rely on any such information in making your decision whether to purchase our shares of common stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="s776938_14"></A>INCORPORATION OF INFORMATION BY REFERENCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The SEC permits us to &#147;incorporate by reference&#148; the information contained in documents we file with the SEC, which means that we
can disclose important information to you by referring you to those documents rather than by including them in this prospectus supplement or the accompanying prospectus. Information that is incorporated by reference is considered to be part of this
prospectus supplement and the accompanying prospectus and you should read it with the same care that you read this prospectus supplement and the accompanying prospectus. Later information that we file with the SEC will automatically update and
supersede the information that is either contained, or incorporated by reference, in this prospectus supplement and the accompanying prospectus, and will be considered to be a part of this prospectus supplement and the accompanying prospectus from
the date those documents are filed. We have filed with the SEC, and incorporate by reference in this prospectus supplement and the accompanying prospectus the following documents; provided, however, that we are not incorporating, in each case, any
documents or information deemed to have been furnished and not filed in accordance with SEC rules: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001177394/000117739424000014/snx-20231130.htm">Form
 <FONT STYLE="white-space:nowrap">10-K</FONT></A> for the fiscal year ended November&nbsp;30, 2023, filed with the SEC on January&nbsp;
26, 2024 (the &#147;2023 Annual Report&#148;), including the portions of our Definitive Proxy Statement on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001177394/000117739424000022/snx-20240205.htm">Schedule 14A
</A> filed on February&nbsp;5, 2024 incorporated by reference into the 2023 Annual Report; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our Quarterly Report on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1177394/000117739424000038/snx-20240229.htm">Form
 10-Q</A> for the fiscal quarter ended February 29, 2024, filed with the SEC on April 4, 2024; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001177394/000117739423000057/snx-20231211.htm">December
<U></U>&nbsp;14, 2023</A>,&nbsp;<A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001177394/000117739424000002/snx-20231231.htm">January<U></U>&nbsp;5, 2024</A>,&nbsp;
<A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001177394/000117739424000008/snx-20240111.htm">January<U></U>&nbsp;
12, 2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001177394/000119312524017563/d744178d8k.htm">January<U></U>&nbsp;
29, 2024 (Items 8.01 and 9.01)</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001177394/000119312524020913/d764319d8k.htm">January<U></U>&nbsp;
31, 2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001177394/000117739424000029/snx-20240228.htm">February<U></U>&nbsp;
29, 2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1177394/000117739424000031/snx-20240320.htm">March<U></U>&nbsp;
21, 2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001177394/000117739424000033/snx-20240326.htm">March 26, 2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1177394/000119312524079521/d767996d8k.htm">March
 28, 2024</A>, and <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1177394/000119312524082062/d653532d8k.htm">March 29, 2024</A>; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The description of our common stock contained in <A HREF="http://www.sec.gov/Archives/edgar/data/1177394/000156459022003003/snx-ex41_1326.htm">Exhibit
 4.1</A> of our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended November&nbsp;30, 2021, including any amendment or report updating such description. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All documents and reports that we file with the SEC (other than any portion of such filings that are furnished under applicable SEC rules
rather than filed) under Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act from the date of this prospectus supplement until the completion of the offering under this prospectus supplement shall be deemed to be incorporated in this prospectus
supplement and the accompanying prospectus by reference. The information contained on or accessible through our website at https://www.tdsynnex.com is not incorporated into this prospectus supplement or the accompanying prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon request, we will provide, without charge, to each person, including any beneficial owner, to whom a copy of this prospectus is delivered,
a copy of any or all of the documents incorporated by reference into this prospectus but not delivered herewith. You may request a copy of these filings, other than an exhibit to these filings unless we have specifically included or incorporated
that exhibit by reference into the filing, from the SEC as described under &#147;Where You Can Find More Information&#148; or, at no cost, by writing or telephoning TD SYNNEX Corporation at the following address: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">TD SYNNEX Corporation </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention:
Corporate Secretary </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16202 Bay Vista Drive </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Clearwater, Florida 33760 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(510) <FONT
STYLE="white-space:nowrap">656-3333</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should not assume that the information in this prospectus supplement, the accompanying
prospectus or any free writing prospectus that we authorize or any documents incorporated by reference is accurate as of any date other than the date of the applicable document. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any statement contained in a document incorporated or deemed to be incorporated by reference into this prospectus supplement or the
accompanying prospectus will be deemed to be modified or superseded for purposes of this prospectus supplement to the extent that a statement contained in this prospectus supplement or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
any other subsequently filed document that is deemed to be incorporated by reference into this prospectus supplement or the accompanying prospectus modifies or supersedes the statement. Any
statement so modified or superseded will not be deemed, except as so modified or superseded, to constitute a part of this prospectus supplement and the accompanying prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PROSPECTUS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g776938g04a04.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>TD SYNNEX Corporation </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus
relates to the offer and resale from time to time by the selling stockholders of TD SYNNEX Corporation listed on page&nbsp;7 of up to an aggregate of 44,961,612 shares of our common stock, par value $0.001 per share, consisting of up to: (a)
35,199,549 shares of our common stock previously registered for resale by certain entities managed by affiliates of Apollo Global Management, Inc. (the &#147;Apollo Selling Stockholders&#148;) pursuant to the prior registration statement on Form <FONT
STYLE="white-space:nowrap">S-3</FONT> filed and which became effective automatically on September&nbsp;2, 2021 (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-259270)</FONT> and (b) 9,762,063 shares of our common stock registered for resale by
certain entities affiliated with MiTAC Holdings Corporation (the &#147;MiTAC Selling Stockholders&#148; and, together with the Apollo Selling Stockholders, the &#147;Initial Selling Stockholders&#148;) pursuant to this registration statement on Form
<FONT STYLE="white-space:nowrap">S-3</FONT> of which this prospectus forms a part, as well as the pledgees, donees, transferees, assignees, successors, designees and others who later come to hold any of the Initial Selling Stockholders&#146;
interest in our common stock other than through a public sale (collectively with the Initial Selling Stockholders, the &#147;Selling Stockholders&#148;). The Apollo Selling Stockholders acquired their shares from us in connection with our
acquisition of Tiger Parent (AP) Corporation (&#147;Tiger Parent&#148;), the indirect parent entity of Tech Data Corporation, a Florida corporation (&#147;Tech Data&#148;). Such shares of common stock were sold and issued by us to the Apollo Selling
Stockholders pursuant to the terms and subject to the conditions of the Agreement and Plan of Merger (the &#147;Merger Agreement&#148;), dated as of March&nbsp;22, 2021, by and among TD SYNNEX Corporation, a Delaware corporation (&#147;TD
SYNNEX,&#148; &#147;we,&#148; &#147;us&#148; or &#147;our&#148;), Spire Sub I, Inc., a Delaware corporation and a wholly-owned subsidiary of SYNNEX (&#147;Merger Sub I&#148;), Spire Sub II, LLC, a Delaware limited liability company and a direct
wholly owned subsidiary of SYNNEX (&#147;Merger Sub II&#148;), and Tiger Parent, and the related agreements. In 1992, MiTAC International Corporation (&#147;MiTAC International&#148;), through its wholly owned subsidiary, Silver Star Development,
Ltd., acquired a controlling interest in us and, prior to the completion of our initial public offering, had increased its beneficial ownership interest in us to approximately 98%. In September 2013, MiTAC Holdings Corporation (&#147;MiTAC
Holdings&#148;) was established through a stock swap from MiTAC International, which is now a wholly owned subsidiary of MiTAC Holdings. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are not selling any shares of our common stock under this prospectus and we will not receive any of the proceeds from the sale of shares by
the Selling Stockholders. Our registration of the shares of our common stock covered by this prospectus does not mean the Selling Stockholders will offer or sell any of the shares of our common stock. The Selling Stockholders may sell the shares of
common stock described in this prospectus through a number of different ways and at varying prices, including through public or private transactions at market prices prevailing at the time of sale or at negotiated prices. We provide more information
about how the Selling Stockholders may sell their shares of common stock in the section of this prospectus entitled &#147;<I>Plan of Distribution</I>.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our common stock is listed on The New York Stock Exchange under the symbol &#147;SNX.&#148; On October&nbsp;9, 2023, the last reported sale
price for our common stock on The New York Stock Exchange was $98.69&nbsp;per share. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:12pt; font-family:Times New Roman"><B>Investing in
our common stock involves a high degree of risk. Before investing, you should carefully consider the matters described under the caption &#147;<A HREF="#tx776938_3">Risk Factors</A>&#148; beginning on page 4. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or
determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The date of
this prospectus is October&nbsp;10, 2023. </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc1"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">Page</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx776938_1">ABOUT THIS PROSPECTUS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">ii</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx776938_2">PROSPECTUS SUMMARY</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx776938_3">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx776938_4">FORWARD-LOOKING STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx776938_5">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx776938_6">SELLING STOCKHOLDERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx776938_7">MATERIAL RELATIONSHIPS WITH SELLING STOCKHOLDERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx776938_8">PLAN OF DISTRIBUTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx776938_9">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx776938_10">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx776938_11">WHERE YOU CAN FIND MORE INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx776938_12">INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx776938_1"></A>ABOUT THIS PROSPECTUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus is part of an automatic shelf registration statement that we filed with the Securities and Exchange Commission (the
&#147;SEC&#148;) as a &#147;well-known seasoned issuer&#148; as defined in Rule 405 under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), utilizing a &#147;shelf&#148; registration process. Under this process, the Selling
Stockholders may sell shares of common stock from time to time in one or more offerings through any means described in the section entitled &#147;<I>Plan of Distribution</I>.&#148; Any applicable prospectus supplement may add, update, or change
information contained in this prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should read this prospectus together with any applicable prospectus supplement, as well as
additional information described under the heading &#147;<I>Where You Can Find More Information</I>.&#148; You should rely only on the information contained or incorporated by reference in this prospectus, any accompanying prospectus supplement and
any applicable &#147;free writing prospectus.&#148; We have not authorized, and the Selling Stockholders have not authorized, anyone else to provide you with different or additional information. No offer of shares of common stock is being made in
any jurisdiction where the offer or sale is not permitted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should not assume that the information in this prospectus, any
accompanying prospectus supplement, or any document incorporated by reference herein or therein is accurate as of any date other than their respective dates. Our business, financial condition, results of operations, and prospects may have changed
since those dates. You should carefully read the entire prospectus, as well as the documents incorporated by reference in the prospectus, any applicable prospectus supplement and any applicable &#147;free writing prospectus&#148; before making an
investment decision. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>References in this prospectus to the terms &#147;the Company,&#148; &#147;TD SYNNEX,&#148; &#147;SYNNEX,&#148;
&#147;we,&#148; &#147;our&#148; and &#147;us&#148; or other similar terms mean TD SYNNEX Corporation and its wholly owned subsidiaries, unless we state otherwise, or the context indicates otherwise. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Throughout this prospectus, when we refer to the shares of our common stock being registered on behalf of the Selling Stockholders, we are
referring to all shares of common stock reported to us as held by such stockholders as of October&nbsp;9, 2023. We agreed to file this prospectus pursuant to an Investor&#146;s Rights Agreement with the Apollo Selling Stockholders dated
September&nbsp;1, 2021 (incorporated by reference to Exhibit 10.1 to the Company&#146;s Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed with the SEC on September&nbsp;2, 2021) and a Letter Agreement with the MiTAC Selling
Stockholders dated September&nbsp;3, 2021 (the &#147;MiTAC Letter Agreement&#148;) (incorporated by reference to Exhibit 4.12 to our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended November&nbsp;30, 2021).
Additional information with respect to the Selling Stockholders is contained in this prospectus under the heading &#147;Selling Stockholders.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">When we refer to the Selling Stockholders in this prospectus, we are referring to the entities named in this prospectus as the Initial Selling
Stockholders and, as applicable, any donees, pledgees, transferees or other <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">successors-in-interest</FONT></FONT> selling shares of common stock or interests in shares of common stock
received after the date of this prospectus from the Initial Selling Stockholders as a gift, pledge, partnership distribution, redemption, repurchase or cancellation, or other <FONT STYLE="white-space:nowrap">non-sale</FONT> related transfer. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx776938_2"></A>PROSPECTUS SUMMARY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>This summary highlights selected information contained elsewhere in this prospectus. This summary does not contain all information that you
should consider before investing in our common stock. You should read the following summary together with the more detailed information regarding TD SYNNEX, the common stock being registered hereby, our financial statements and notes thereto and our
risk factors, before deciding whether to purchase shares of our common stock from the Selling Stockholders. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Company Overview </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are a Fortune 100 corporation and a leading provider of a comprehensive range of distribution, systems design, and integration services for
the technology industry. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We distribute PC systems, mobile phones and accessories, printers, peripherals, information technology
(&#147;IT&#148;) systems including data center server and storage solutions, system components, software, networking, communications and security equipment, consumer electronics and complementary products. We also provide systems design and
integration solutions. We distribute more than 200,000 technology products (as measured by active SKUs) from more than 1,500 original equipment manufacturers, as well as suppliers of next- generation technologies and delivery models such as
converged and hyper-converged infrastructure, the cloud, security, big data/analytics/Internet of things and services. Our products are marketed globally to an active reseller base of more than 150,000 resellers, system integrators, and retailers.
We purchase peripherals, IT systems, system components, software, networking, communications and security equipment, consumer electronics and complementary products from our suppliers and sell them to our reseller and retail customers. We perform a
similar function for our distribution of licensed software products. Our reseller customers include value-added resellers, corporate resellers, government resellers, system integrators, direct marketers, retailers and managed service providers. We
provide our vendors with access to large and highly fragmented markets such as small- and <FONT STYLE="white-space:nowrap">medium-sized</FONT> businesses and serve as a variable, cost effective route to market for our vendors by providing them with
access to resellers and <FONT STYLE="white-space:nowrap">end-users.</FONT> We combine our core strengths in distribution with demand generation, supply chain management and design and integration solutions to help our customers achieve greater
efficiencies in time to market, cost minimization, real-time linkages in the supply chain and aftermarket product support. We also provide comprehensive IT solutions in key vertical markets such as government and healthcare and we provide
specialized service offerings that increase efficiencies in the areas of global computing components, logistics services and supply chain management. Additionally, we provide our customers with systems design and integration solutions for data
center servers and networking solutions built specific to our customers&#146; workloads and data center environments. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Corporate Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have been in business since 1980 and have headquarters in both Clearwater, Florida and Fremont, California. We were originally incorporated
in the State of California as COMPAC Microelectronics, Inc. in November 1980, and we changed our name to SYNNEX Information Technologies, Inc. in February 1994. We later reincorporated in the State of Delaware under the name of SYNNEX Corporation in
October 2003. As a result of the Mergers (as defined below), on October 22, 2021, we filed with the Secretary of State of the State of Delaware a Certificate of Amendment to the Company&#146;s Restated Certificate of Incorporation to change our
corporate name from SYNNEX Corporation to TD SYNNEX Corporation, effective November 3, 2021. Our common stock is listed on The New York Stock Exchange under the symbol &#147;SNX.&#148; Our principal executive offices are located at 44201 Nobel
Drive, Fremont, California 94538, and our telephone number is (510) <FONT STYLE="white-space:nowrap">656-3333.</FONT> </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Merger Transactions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September 1, 2021, we completed our acquisition of Tiger Parent (AP) Corporation, a Delaware Corporation (&#147;Tiger Parent&#148;), which
is the parent corporation of Tech Data Corporation, a Florida corporation (&#147;Tech Data&#148;). The acquisition was completed pursuant to the terms and conditions of the Agreement and Plan of Merger (the &#147;Merger Agreement&#148;), dated
March&nbsp;22, 2021 by and among SYNNEX Corporation, Spire Sub I, Inc., a Delaware corporation and a wholly owned subsidiary of SYNNEX Corporation (&#147;Merger Sub I&#148;), Spire Sub II, LLC, a Delaware limited liability company and a wholly owned
subsidiary of SYNNEX Corporation (&#147;Merger Sub II&#148;), and Tiger Parent, pursuant to which, subject to the terms and conditions of the Merger Agreement, Merger Sub I merged with and into Tiger Parent (the &#147;Initial Merger&#148;), with
Tiger Parent surviving the Initial Merger as a wholly owned subsidiary of SYNNEX Corporation (such surviving corporation, the &#147;Surviving Corporation&#148;), followed immediately by the merger of the Surviving Corporation with and into Merger
Sub II (the &#147;Subsequent Merger&#148; and together with the Initial Merger, the &#147;Mergers&#148;), with Merger Sub II surviving the Subsequent Merger as a wholly owned subsidiary of SYNNEX Corporation. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The Offering </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Common stock registered for resale by the Selling Stockholders </P></TD>
<TD>44,961,612 shares </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">The New York Stock Exchange symbol </P></TD>
<TD>SNX </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Use of proceeds </P></TD>
<TD>All of the shares of common stock being offered under this prospectus are being sold by the Selling Stockholders. Accordingly, we will not receive any proceeds from the sale of these shares. </TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx776938_3"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Investing in our securities involves risk. Prior to making a decision about investing in our securities, you should carefully consider the
specific factors discussed below and under the heading &#147;Risk Factors&#148; contained in our most recent Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> and most recent Quarterly Reports on Form
<FONT STYLE="white-space:nowrap">10-Q</FONT> and any other filings we make with the SEC from time to time that are incorporated herein by reference, as well as the &#147;Risk Factors&#148; contained in any prospectus supplement, together with all of
the other information contained or incorporated by reference in this prospectus or any prospectus supplement. See &#147;Where You Can Find More Information&#148; in this prospectus. The risks and uncertainties we have described therein and below are
not the only risks that we face. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also affect our operations. In that case, the trading price of our common stock could decline. </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Sales or the availability for sale of a substantial number of shares of our common stock in the public market could cause our stock
price to be volatile or fall. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Sales of a substantial number of shares of our common stock in the public market or the perception
that these sales might occur could abruptly depress the market price of our common stock and could impair our ability to raise capital through the sale of additional equity securities. As of August&nbsp;31, 2023, we had approximately 92,737,234
shares of our common stock outstanding, 38.0% of which is held by the Apollo Selling Stockholders and 10.5% of which is held by the MiTAC Selling Stockholders. The Selling Stockholders may choose to sell some or all or none of their shares of common
stock. The sale or the availability for sale of a large number of shares of our common stock in the public market from time to time could increase the potential for stock price volatility or cause the price of our common stock to decline. Even if we
put strategies in place to attempt to address potential or actual volatility, the effectiveness of such strategies is uncertain. In addition, the Selling Stockholders have certain registration rights that require us to register the sale of common
stock held by them, including in connection with underwritten offerings. Further, certain of the Selling Stockholders have pledged a significant number of the shares of common stock held by them pursuant to margin loan agreements, and any
foreclosure upon those shares could result in sales of a substantial number of shares of our common stock in the public market, which could substantially decrease the market price of our common stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Our bylaws provide that the Court of Chancery of the State of Delaware will be the exclusive forum for substantially all disputes
between us and our stockholders, which could limit our stockholders&#146; ability to obtain a favorable judicial forum for disputes with us or our directors, officers or employees. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our bylaws provide that the Court of Chancery of the State of Delaware (or, if the Court of Chancery does not have jurisdiction, the federal
district court for the District of Delaware) is the exclusive forum for (i)&nbsp;any derivative action or proceeding brought on behalf of the corporation, (ii)&nbsp;any action asserting a claim of breach of fiduciary duty owed by any current or
former director, officer, other employee or agent of the corporation to the corporation or the corporation&#146;s stockholders, including a claim alleging the aiding and abetting of such a breach of fiduciary duty, (iii)&nbsp;any action asserting a
claim arising pursuant to any provision of the Delaware General Corporation Law or the bylaws or the certificate of incorporation or (iv)&nbsp;any action asserting a claim governed by the internal affairs doctrine or asserting an &#147;internal
corporate claim&#148;. This choice of forum provision may limit a stockholder&#146;s ability to bring a claim in a different judicial forum that such stockholder views as more favorable for such disputes which may discourage such lawsuits against us
and our directors, officers and other employees. Alternatively, if a court were to find the choice of forum provisions contained in our bylaws to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving
such action in other jurisdictions, which could adversely affect our business and financial condition. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx776938_4"></A>FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Forward-looking statements included in this prospectus, any prospectus supplement, information incorporated by reference herein or therein and
any related free-writing prospectus are based on various facts and derived utilizing numerous important assumptions are subject to known and unknown risks, uncertainties and other factors that may cause our actual results, performance or
achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements include the information concerning our future financial performance,
business strategy, projected plans and objectives, as well as projections of macroeconomic and industry trends, which are inherently unreliable due to the multiple factors that impact economic trends, and any such variations may be material.
Statements preceded by, followed by or that otherwise include the words &#147;believes,&#148; &#147;expects,&#148; &#147;anticipates,&#148; &#147;intends,&#148; &#147;projects,&#148; &#147;estimates,&#148; &#147;plans,&#148; and similar expressions
or future or conditional verbs such as &#147;will,&#148; &#147;should,&#148; &#147;would,&#148; &#147;may&#148; and &#147;could&#148; are generally forward looking in nature and not historical facts. Factors that could cause our actual results to
differ materially from those described in the forward-looking statements include, but are not limited to, those discussed in the section entitled &#147;Risk Factors&#148; contained herein and in any Annual Report on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> and any Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> incorporated by reference in this prospectus and in the section of any related prospectus supplement entitled &#147;Risk Factors.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as required by law, we undertake no obligation to update any forward-looking statements in order to reflect any event or
circumstance that may arise after the date of this prospectus. However, readers should carefully review the reports and documents we file or furnish from time to time with the SEC, particularly our annual reports on Form <FONT
STYLE="white-space:nowrap">10-K,</FONT> quarterly reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> and current reports on Form <FONT STYLE="white-space:nowrap">8-K.</FONT> For information about how to obtain a copy of these reports or
other documents that we file with the SEC, see &#147;<I>Where You Can Find More Information</I>&#148; in this prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx776938_5"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Selling Stockholders will make offers and sales pursuant to this prospectus and any applicable prospectus supplement. We will not receive
any proceeds from the sale or other disposition by the Selling Stockholders of the shares of our common stock covered hereby, or interests therein. The Selling Stockholders will pay all applicable underwriting fees, discounts and similar charges
(pro rata based on the securities sold). The Selling Stockholders shall be entitled to a single counsel at our expense to be selected by the Selling Stockholders. We will bear all other costs, fees and expenses incurred in effecting the registration
of the shares covered by this prospectus, including, without limitation, all registration fees, listing fees of The New York Stock Exchange and fees and expenses of our counsel and our independent registered public accounting firm. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx776938_6"></A>SELLING STOCKHOLDERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are registering for resale an aggregate of up to 44,961,612 shares of our common stock that may be sold by the Initial Selling Stockholders
set forth herein, as well as the pledgees, donees, transferees, assignees, successors, designees and others who later come to hold any of the Initial Selling Stockholders&#146; interest in our common stock other than through a public sale
(collectively with the Initial Selling Stockholders, the &#147;Selling Stockholders&#148;). Such shares were sold and issued by us to: (a)&nbsp;the former sole stockholder of Tiger Parent pursuant to the terms of the Merger Agreement and the related
agreements, and (b)&nbsp;the MiTAC Selling Stockholders, in each case under an exemption from registration under Section&nbsp;4(a)(2) of the Securities Act. In January 2023, an aggregate of 5,175,000 shares of common stock were sold by the Apollo
Selling Stockholders pursuant to the Prior Registration Statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Beneficial ownership is determined in accordance with the rules of the
SEC and includes voting or investment power with respect to our common stock. Under rules of the SEC, a person is deemed to be a &#147;beneficial owner&#148; of a security if that person has or shares voting power or investment power, which includes
the power to dispose of or to direct the disposition of such security. A person is also deemed to be a beneficial owner of any securities of which that person has a right to acquire beneficial ownership within 60 days. Securities that can be so
acquired are deemed to be outstanding for purposes of computing such person&#146;s ownership percentage, but not for purposes of computing any other person&#146;s percentage. Under these rules, more than one person may be deemed to be a beneficial
owner of the same securities, and a person may be deemed to be a beneficial owner of securities as to which such person has no economic interest. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Selling Stockholders may sell some, all, or none of their shares of common stock offered by this prospectus from time to time. Other than
the Merger Agreement and the agreements contemplated thereby or described below, we currently have no agreements, arrangements or understandings with the Selling Stockholders regarding the sale of any of the shares of common stock being offered
hereunder. Other than the rights provided to the Apollo Selling Stockholders pursuant to that certain Investor&#146;s Rights Agreement dated September&nbsp;1, 2021 (filed as Exhibit 10.1 to our Current Report on Form
<FONT STYLE="white-space:nowrap">8-K</FONT> filed with the SEC on September&nbsp;2, 2021), and the MiTAC Letter Agreement, dated as of September&nbsp;3, 2021, by and between SYNNEX Corporation, Silver Star Developments Ltd. And Peer Developments
Ltd. (filed as Exhibit 4.12 to our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended November&nbsp;30, 2021) and as otherwise described herein, none of the Selling Stockholders have, and within the past three
years have had, any position, office or other material relationship with us or any of our affiliates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Selling Stockholder information for
any additional Selling Stockholders, if any, will be set forth by prospectus supplement to the extent required prior to the time of any offer or sale of such Selling Stockholders&#146; shares pursuant to this prospectus. Any prospectus supplement
may add, update, substitute, or change the information contained in this prospectus, including the identity of the Selling Stockholders and the number of shares registered on their behalf. Any of the Selling Stockholders may sell or otherwise
transfer all, some or none of such shares in this offering. See &#147;<I>Plan of Distribution</I>.&#148; </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="46%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Prior to the Offering</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>After the Offering</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>Name of Selling Stockholder</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Shares of<BR>Common<BR>Stock<BR>Beneficially<BR>Owned</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percent of<BR>Shares of<BR>Common<BR>Stock<BR>Outstanding&nbsp;<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Shares of<BR>Common<BR>Stock Being<BR>Registered<BR>for<BR>Resale <SUP STYLE="font-size:75%; vertical-align:top">(2)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Shares of<BR>Common<BR>Stock<BR>Beneficially<BR>Owned <SUP STYLE="font-size:75%; vertical-align:top">(3)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percent of<BR>Shares of<BR>Common<BR>Stock<BR>Outstanding</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities managed by affiliates of Apollo Global Management Inc.<SUP
STYLE="font-size:75%; vertical-align:top">(4)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35,199,549</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35,199,549</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with MiTAC Holdings Corporation and related parties<SUP
STYLE="font-size:75%; vertical-align:top">(5)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,762,063</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.5</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,762,063</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Based on 92,737,234 shares outstanding as of August&nbsp;31, 2023. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents the number of shares being registered on behalf of the Selling Stockholder pursuant to this
registration statement, which may be less than the total number of shares beneficially owned by such Selling Stockholder. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Assumes that the Selling Stockholders dispose of all of the shares of common stock covered by this prospectus
and do not acquire beneficial ownership of any additional shares. The registration of these shares does not necessarily mean that the Selling Stockholders will sell all or any portion of the shares covered by this prospectus. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Tiger Parent Holdings, L.P. (&#147;Tiger Holdings&#148;), AP IX Tiger Holdings, L.P. (&#147;AP IX Tiger&#148;),
AP IX Tiger <FONT STYLE="white-space:nowrap">Co-Invest</FONT> II, L.P. (&#147;Tiger <FONT STYLE="white-space:nowrap">Co-Invest&#148;)</FONT> and AP IX Tiger <FONT STYLE="white-space:nowrap">Co-Invest</FONT> (ML), L.P. (&#147;Tiger <FONT
STYLE="white-space:nowrap">Co-Invest</FONT> ML&#148;) each hold shares of the Company. The shares of common stock to be sold in this offering are held by AP IX Tiger, Tiger <FONT STYLE="white-space:nowrap">Co-Invest,</FONT> Tiger <FONT
STYLE="white-space:nowrap">Co-Invest</FONT> ML, and Tiger Holdings. Tiger Parent Holdings GP, LLC (&#147;Tiger GP&#148;) is the general partner of Tiger Holdings. AP IX Tiger is the sole member of Tiger GP. AP IX Tiger
<FONT STYLE="white-space:nowrap">Co-Invest</FONT> (ML)&nbsp;GP, LLC (&#147;Tiger <FONT STYLE="white-space:nowrap">Co-Invest</FONT> ML GP&#148;) is the general partner of Tiger <FONT STYLE="white-space:nowrap">Co-Invest</FONT> ML. AP IX Tiger
Holdings GP, LLC (&#147;AP IX Tiger GP&#148;) is the general partner of each of AP IX Tiger and Tiger <FONT STYLE="white-space:nowrap">Co-Invest,</FONT> and the sole member of Tiger <FONT STYLE="white-space:nowrap">Co-Invest</FONT> ML GP. Apollo
Management IX, L.P. (&#147;Management IX&#148;) is the <FONT STYLE="white-space:nowrap">non-member</FONT> manager of AP IX Tiger GP. The general partner of Management IX is AIF IX Management, LLC (&#147;AIF IX LLC&#148;). Apollo Management, L.P.
(&#147;Apollo LP&#148;) is the sole member and manager of AIF IX LLC. Apollo Management GP, LLC (&#147;Management GP&#148;) is the general partner of Apollo LP. Apollo Management Holdings, L.P. (&#147;Management Holdings&#148;) is the sole member of
Management GP. Apollo Management Holdings GP, LLC (&#147;Management Holdings GP&#148;) is the general partner of Management Holdings. Each of the entities listed herein, other than Tiger Holdings, AP IX Tiger, Tiger
<FONT STYLE="white-space:nowrap">Co-Invest,</FONT> and Tiger <FONT STYLE="white-space:nowrap">Co-Invest</FONT> ML, disclaims beneficial ownership of any shares of the common stock owned of record by Tiger Holdings, AP IX Tiger, Tiger <FONT
STYLE="white-space:nowrap">Co-Invest,</FONT> and Tiger <FONT STYLE="white-space:nowrap">Co-Invest</FONT> ML, except to the extent of any pecuniary interest therein. Joshua Harris, Scott Kleinman, Marc Rowan and James Zelter are the managers, as well
as executive officers, of Management Holdings GP. Each of the entities listed above, other than Tiger Parent Holdings, L.P., and each of Messrs. Harris, Kleinman, Rowan and Zelter, disclaims beneficial ownership of any shares of the Company&#146;s
common stock owned of record by Tiger Parent Holdings, L.P. The address of the principal office of each of Tiger GP, Tiger <FONT STYLE="white-space:nowrap">Co-Invest</FONT> ML GP, and AP IX Tiger GP is One Manhattanville Road, Suite 201, Purchase,
New York 10577. The address of the principal office of each of Tiger Holdings, AP IX Tiger, Tiger <FONT STYLE="white-space:nowrap">Co-Invest,</FONT> Tiger <FONT STYLE="white-space:nowrap">Co-Invest</FONT> ML, and Management Holdings is One
Manhattanville Road, Suite 201, Purchase, New York 10577. The address of the principal office of each of Management IX, AIF IX LLC, Apollo LP, Management GP, and Management Holdings GP is 9 West 57th Street, New York, NY10019. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The proceeds of the shares offered by Tiger Holdings will be distributed to certain members of management of the Company. Such members of
management had been members of management of Tech Data Corporation and had exchanged their profits interests of Tiger Holdings on August&nbsp;26, 2021 for the right to receive shares of the Company. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Based on information reported on a Schedule 13G/A filed with the SEC on February&nbsp;13, 2023 and a subsequent
Form 4 filed with the SEC on April&nbsp;5, 2023, this amount includes 2,594,649 shares held by MiTAC International Corporation (&#147;MIC&#148;), 2,403,229 shares held by MiTAC Holdings Corporation (&#147;MHC&#148;), 302,102 shares held by Silver
Star Developments Ltd. (&#147;SSDL&#148;) and 3,859,888 shares held by Peer Developments Ltd. (&#147;PEER&#148;). SSDL is a wholly owned subsidiary of MIC, and MIC is a wholly owned subsidiary of MHC. The principal business office for MIC and SSDL
is No.&nbsp;200 Wenhua 2nd Road, Guishan Dist., Taoyuan City 333, Taiwan. <FONT STYLE="white-space:nowrap">Jhi-Wu</FONT> Ho and <FONT STYLE="white-space:nowrap">Hsiang-Yun</FONT> Yang, the directors of SSDL, hold shared voting and dispositive power
over the shares held by SSDL. PEER is a wholly owned subsidiary of Synnex Technology International Corporation (&#147;Synnex Technology&#148;). The principal business office for Synnex Technology and PEER is 4th Floor, No.&nbsp;75 Sec. 3, Minsheng
East Road, Zhongshan Dist., Taipei City 104, Taiwan. Matthew F.C. Miau and <FONT STYLE="white-space:nowrap">Shu-Wu</FONT> Tu, the directors of PEER, hold shared voting and dispositive power over the shares held by PEER. Matthew F.C. Miau is the
Chairman of the board of directors of MIC and Synnex Technology and a director of TD SYNNEX. Each of the reporting persons disclaims membership in a group. The beneficial ownership of the 602,195 shares Matthew F.C. Miau
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
claims includes 195,542 shares directly held by Mr.&nbsp;Miau, 217,050 shares indirectly held by MASJ Holding Charitable Remainder Trust, and 189,603 shares indirectly held by
Mr.&nbsp;Miau&#146;s spouse. In addition, MIC disclaims beneficial ownership of the 3,859,888 shares directly held by PEER and disclaims beneficial ownership of the 602,195 shares by Mr.&nbsp;Miau. Synnex Technology disclaims beneficial ownership of
the 302,102 shares directly held by SSDL and disclaims beneficial ownership of the 602,195 shares by Mr.&nbsp;Miau. Mr.&nbsp;Miau disclaims beneficial ownership of the 2,594,649 shares held by MIC, 2,403,229 shares held by MHC, 302,102 shares
directly held by SSDL and disclaims beneficial ownership of the 3,859,888 shares directly held by PEER. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx776938_7"></A>MATERIAL RELATIONSHIPS WITH SELLING STOCKHOLDERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Apollo </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Apollo Global Management, Inc.
(&#147;Apollo&#148; and, together with its affiliates (including the Selling Stockholders), the &#147;Apollo Entities&#148;) is an affiliate of the Company. Without giving effect to any resale of shares of common stock pursuant to this prospectus,
the Apollo Entities beneficially owned approximately 38.0% of outstanding shares of our common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Apollo Entities acquired these
shares from us in connection with our acquisition of Tiger Parent, the indirect parent entity of Tech Data. Such shares of common stock were sold and issued by us to the Apollo Entities pursuant to the terms and subject to the conditions of the
Merger Agreement. Additionally, in connection with the completion of the Mergers, we entered into an Investor Rights Agreement (the &#147;Investor Rights Agreement&#148;) with Tiger Holdings, an affiliate of Apollo. Pursuant to the Investor Rights
Agreement, the Apollo Entities have the right to nominate (i)&nbsp;up to four directors if the Apollo Entities own 30% or more of the outstanding shares of our common stock, (ii)&nbsp;up to three directors if the Apollo Entities own between 20% and
30% of the outstanding shares of our common stock, (iii)&nbsp;up to two directors, if the Apollo Entities own between 10% and 20% of the outstanding shares of our common stock or (iv)&nbsp;up to one director, if the Apollo Entities own between 5%
and 10% of the outstanding shares of our common stock (such directors nominated by the Apollo Entities, the &#147;Apollo Directors&#148;). The current Apollo Directors are Robert Kalsow-Ramos, Nayaki Nayyar, Matthew Nord, and Merline Saintil. The
Investor Rights Agreement also provides that, of the remaining directors who are not Apollo Directors, one director shall be the then-serving Chief Executive Officer of the Company, currently Richard Hume, and the other directors will be nominated
in accordance with the provisions of our bylaws and Certificate of Incorporation. The Apollo Directors must fulfill their pro rata portion of any diversity requirements pursuant to law, stock exchange rules, or other regulatory requirements based on
the percentage of our board of directors consisting of Apollo Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Investor Rights Agreement, we have waived the
corporate opportunity doctrine to the extent permitted under the Delaware General Corporation Law with respect to the Apollo Directors and Apollo Entities, so long as such person is not an employee of the Company or our subsidiaries (the
&#147;Covered Persons&#148;). Specifically, we agreed that the Covered Persons do not have a duty to refrain from: (i)&nbsp;investing in or conducting any business of any kind, (ii)&nbsp;doing business with our or any of our affiliates&#146;
clients, customers, vendors or lessors, or (iii)&nbsp;making any investments in any kind of property in which we may make investments. Further, we agreed, among other things, subject to any express agreement otherwise that may from time to time be
in effect, that if a Covered Person acquires knowledge of a potential transaction which may constitute a corporate opportunity for both (a)&nbsp;the Covered Person outside of his or her capacity as a member of our board of directors and (b)&nbsp;the
Company, then the Covered Person shall not have any duty to offer or communicate information regarding such corporate opportunity to us, and we renounced any interest or expectancy in any potential transaction or matter of which the Covered Person
acquires knowledge, except for any corporate opportunity which is expressly offered to a Covered Person in writing solely in his or her capacity as a member of our board of directors, or as expressly agreed otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, we granted the Apollo Entities certain registration rights pursuant to the Investor Rights Agreement. Subject to several
exceptions, including our right to defer a demand registration, underwritten shelf registration or <FONT STYLE="white-space:nowrap">non-underwritten</FONT> shelf registration under certain circumstances, the Apollo Entities have the right to require
us to register the sale of the shares of common stock held by them on Form <FONT STYLE="white-space:nowrap">S-3,</FONT> subject to offering size and other restrictions. The Apollo Entities also have the right to request marketed and <FONT
STYLE="white-space:nowrap">non-marketed</FONT> underwritten offerings using a shelf registration statement. If we propose to file certain types of registration statements under the Securities Act with respect to an offering of shares of common stock
(including for sale by us or at the request of any holder of registration rights), then we will be required to offer the Apollo Entities the opportunity to register any number of shares of common stock that they request, on the terms and conditions
set forth in the Investor Rights Agreement (customarily known as &#147;piggyback rights&#148;). The registration rights granted under the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Investor Rights Agreement are subject to customary restrictions including, if a registration is underwritten, any limitations on the number of shares to be included in the underwritten offering
as reasonably advised by the managing underwriter or underwriters. All expenses of registration under the Investor Rights Agreement, including the legal fees of counsel chosen by the Apollo Entities, but excluding all applicable underwriting fees,
discounts and similar charges, will be paid by us. The Investor Rights Agreement also contains customary indemnification and contribution provisions. Any sales in the public market of any shares of common stock registrable pursuant to the
registration rights granted under the Investor Rights Agreement could depress the market price of our shares of common stock. See &#147;Risk Factors&#151;Sales or the availability for sale of a substantial number of shares of our common stock in the
public market could cause our stock price to be volatile or fall.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our director Robert Kalsow-Ramos is a Partner, Private Equity at
Apollo and our director Matthew Nord is a Partner and <FONT STYLE="white-space:nowrap">Co-Head</FONT> of Private Equity at Apollo. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>MiTAC Holdings
Corporation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have a business relationship with MiTAC International Corporation (&#147;MiTAC International&#148;), a publicly-traded
company in Taiwan that began in 1992 when it became our primary investor through its affiliates. In September 2013, MiTAC Holdings Corporation (&#147;MiTAC Holdings&#148;) was established through a stock swap from MiTAC International and became a
publicly traded company on the Taiwan Stock Exchange. MiTAC International is now a wholly owned subsidiary of MiTAC Holdings. As of August&nbsp;31, 2023, MiTAC Holdings and its affiliates beneficially owned approximately 10.5% of our common stock.
Matthew Miau, our Chair Emeritus of the Board and a director, is the Chairman of MiTAC Holdings and a director or officer of MiTAC Holdings&#146; affiliates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Until July&nbsp;31, 2010, we worked with MiTAC Holdings on OEM outsourcing and jointly marketed MiTAC Holdings&#146; design and electronic
manufacturing services and our contract assembly capabilities. On July&nbsp;31, 2010, MiTAC Holdings purchased certain assets related to the contract assembly business including inventory and customer contracts, primarily related to customers then
being jointly serviced by MiTAC Holdings and us. We made payments of $0.4&nbsp;million and $0.2&nbsp;million to MiTAC Holdings and its affiliates for reimbursement of rent and overhead costs for facilities used by us during fiscal years ended
November&nbsp;30, 2022 and 2021, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We purchased inventories and services from MiTAC Holdings and its affiliates totaling
$257.7&nbsp;million, $199.7 and $211.9&nbsp;million during fiscal years 2022, 2021 and 2020, respectively. Our sales to MiTAC Holdings, and its affiliates during fiscal years 2022, 2021 and 2020 totaled $1.3&nbsp;million, $0.6&nbsp;million and
$0.8&nbsp;million, respectively. Most of the purchases and sales in 2022, 2021 and 2020 were pursuant to the agreements mentioned under the heading &#147;Agreements with MiTAC Holdings and Affiliates&#148; below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our business relationship with MiTAC Holdings and its affiliates has been informal and is not governed by long-term commitments or
arrangements with respect to pricing terms, revenue or capacity commitments. We negotiate pricing and other material terms on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">case-by-case</FONT></FONT> basis with MiTAC Holdings
and its affiliates. We have adopted a policy requiring that material transactions with MiTAC Holdings or its related parties be approved by the Audit Committee, which is composed solely of independent directors. In addition, Matthew Miau&#146;s
compensation is approved by the Nominating and Corporate Governance Committee and will be approved by the Compensation Committee going forward, which are also composed solely of independent directors. While the ownership structure of MiTAC Holdings
and its affiliates is complex, it has not had a material adverse effect on our business in the past, and we do not expect it to do so in the future. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Agreements with MiTAC Holdings and Affiliates </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have entered into several additional agreements with affiliates of MiTAC Holdings. These agreements do not constitute contracts or
obligations by any party to purchase products or services from the other parties, nor do they restrict our ability to conduct our business. Accordingly, we do not believe that the termination of any of
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
these agreements would have a material adverse effect on our business. Pursuant to these agreements, the terms for contracted services or purchased products are individually negotiated and, if
agreed upon by the parties, such terms are included in a purchase order. In the fiscal years ended November&nbsp;30, 2022, 2021 and 2020, we paid an aggregate of approximately $257.7&nbsp;million, $199.7&nbsp;million and $211.9&nbsp;million to MiTAC
Holdings and its affiliates, most of which was paid pursuant to certain distribution and supply agreements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Letter Agreement</I>. In
connection with the Mergers and the Investor Rights Agreement, we entered into a letter agreement (the &#147;Letter Agreement&#148;) with Silver Star Developments Ltd., Peer Developments Ltd., and any of their affiliates that becomes an owner of TD
SYNNEX common stock (the &#147;MiTAC Stockholders&#148;). Under the Letter Agreement, we have agreed that, in the event we file a registration statement with respect to an underwritten offering or a shelf registration statement, whether on our own
account or otherwise, or we receive an underwritten shelf take-down notice, then the MiTAC Stockholders shall be given notice thereof, and shall be entitled to include in such filings the shares of TD SYNNEX common stock held by them, subject to
certain underwriter cutbacks. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For more information on these relationships, please refer to the 2022 Annual Report, which is incorporated
herein by reference. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx776938_8"></A>PLAN OF DISTRIBUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Selling Stockholders may, from time to time in one or more transactions on The New York Stock Exchange or any other organized market where
our shares of common stock may be traded, sell any or all of their shares of our common stock offered hereby through underwriters, dealers or agents, directly to one or more purchasers or through a combination of any such methods of sale. The
Selling Stockholders may distribute the shares of our common stock offered hereby from time to time in one or more transactions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at a fixed price or prices, which may be changed; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at market prices prevailing at the time of sale; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at prices related to such prevailing market prices; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at negotiated prices. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Selling Stockholders may use any one or more of the following methods when selling the shares offered hereby: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">one or more block trades in which the broker-dealer will attempt to sell such shares as agent or principal of all
of such shares held by the Selling Stockholders; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">purchases by a broker-dealer as principal and resale by such broker-dealer for its account;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an exchange distribution in accordance with the rules of the applicable exchange; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">through trading plans entered into by a Selling Stockholder pursuant to Rule
<FONT STYLE="white-space:nowrap">10b5-1</FONT> under the Securities Exchange Act of 1934 (the &#147;Exchange Act&#148;) that are in place at the time of an offering pursuant to this prospectus and any applicable prospectus supplement hereto that
provide for periodic sales of their securities on the basis of parameters described in such trading plans; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">settlement of short sales effected after the date of this prospectus; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">through the writing or settlement of options or other hedging transactions, whether through an options exchange
or otherwise; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">through one or more underwritten offerings on a firm commitment or best efforts basis; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">privately negotiated transactions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">agreements between broker-dealers and the Selling Stockholders to sell a specified number of such shares at a
stipulated price per share; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a combination of any such methods of sale; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other method permitted pursuant to applicable law. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, any shares covered by this prospectus that qualify for resale pursuant to Rule 144 under the Securities Act may be sold under
Rule 144 rather than under this prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the Selling Stockholders effect such transactions by selling shares of common stock
offered hereby to or through underwriters, broker-dealers or agents, such underwriters, broker-dealers or agents may receive commissions in the form of discounts, concessions or commissions from the Selling Stockholders or commissions from
purchasers of the shares of common stock offered hereby for whom they may act as agent or to whom they may sell as principal (which discounts, concessions or commissions as to particular underwriters, broker-dealers or agents may be in excess of
those customary in the types of transactions involved). The Selling Stockholders reserve the right to accept and, together with their agents from time to time, to reject, in whole or in part, any proposed purchase of common stock to be made directly
or through agents. We will not receive any of the proceeds from sales of our common stock by the Selling Stockholders. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Selling Stockholders may, from time to time, pledge or grant a security interest in some
or all of the shares of common stock offered hereby and owned by them and, if they default in the performance of their secured obligations, the pledgees or secured parties may offer and sell such shares of common stock from time to time pursuant to
this prospectus or any amendment to this prospectus under Rule 424(b)(3) or other applicable provision of the Securities Act, amending, if necessary, the list of Selling Stockholders to include the pledgee, transferee or other successors in interest
as Selling Stockholders under this prospectus. The Selling Stockholders also may transfer and donate the shares of common stock offered hereby in other circumstances, in which case the transferees, donees, pledgees or other successors in interest
will be the selling beneficial owners for purposes of this prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, a Selling Stockholder that is an entity may elect to
make a pro rata <FONT STYLE="white-space:nowrap">in-kind</FONT> distribution of securities to its members, partners or stockholders or purchase or redeem interests held in such entity by its members, partners or stockholders in exchange for
securities, in each case pursuant to the registration statement of which this prospectus is a part by delivering a prospectus with a plan of distribution. Such members, partners or stockholders (unless our affiliate) would thereby receive freely
tradeable securities pursuant to the distribution through a registration statement. To the extent a distributee is an affiliate of ours (or to the extent otherwise required by law), we may file a prospectus supplement in order to permit the
distributees to use the prospectus to resell the securities acquired in the distribution. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the sale of our common stock
or interests therein, the Selling Stockholders may enter into hedging transactions with broker-dealers or other financial institutions, which may in turn engage in short sales of the common stock in the course of hedging the positions they assume.
The Selling Stockholders may also sell shares of our common stock short and deliver these securities to close out the short positions, or loan or pledge the common stock to broker-dealers that in turn may sell these securities. The Selling
Stockholders may also enter into option or other transactions with broker-dealers or other financial institutions or the creation of one or more derivative securities which require the delivery to such broker-dealer or other financial institution of
shares offered by this prospectus, which shares such broker-dealer or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Selling Stockholders and any broker-dealers or agents that participate in the distribution of the shares of common stock covered by this
prospectus may be deemed to be &#147;underwriters&#148; within the meaning of the Securities Act. Any discounts, commissions, concessions or profit they earn on any resale of the shares may be underwriting discounts and commissions under the
Securities Act. Selling Stockholders who are deemed to be &#147;underwriters&#148; within the meaning of the Securities Act will be subject to the prospectus delivery requirements of the Securities Act. To the extent required, the shares of our
common stock to be sold, the names of the Selling Stockholders, the respective purchase prices and public offering prices, the names of any agents or dealers, and any applicable discounts, commissions, concessions or other compensation with respect
to a particular offer will be set forth in an accompanying prospectus supplement or, if appropriate, a post-effective amendment to the registration statement that includes this prospectus. Underwriters and their controlling persons, dealers and
agents may be entitled, under agreements entered into with us and the Selling Stockholders, to indemnification against and contribution toward specific civil liabilities, including liabilities under the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have agreed to indemnify the Selling Stockholders against certain liabilities, including liabilities under the Securities Act, relating to
the registration of the shares offered by this prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the securities laws of some states, the shares of common stock offered
hereby may be sold in such states only through registered or licensed brokers or dealers. In addition, in some states the shares of common stock offered hereby may not be sold unless such shares have been registered or qualified for sale in such
state or an exemption from registration or qualification is available and is complied with. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There can be no assurance that the Selling
Stockholders will sell any or all of the shares of common stock registered pursuant to the registration statement of which this prospectus forms a part. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Selling Stockholders and any other person participating in such distribution will be
subject to applicable provisions of the Exchange Act, and the rules and regulations thereunder, including, without limitation, Regulation M of the Exchange Act, which may limit the timing of purchases and sales of any of the shares of common stock
offered hereby by the Selling Stockholders and any other participating person. Regulation M may also restrict the ability of any person engaged in the distribution of the shares of common stock offered hereby to engage in market-making activities
with respect to the shares of common stock offered hereby. All of the foregoing may affect the marketability of the shares of common stock offered hereby and the ability of any person or entity to engage in market-making activities with respect to
the shares of common stock offered hereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Once sold under the registration statement, of which this prospectus forms a part, the shares
of common stock offered hereby will be freely tradable in the hands of persons other than our affiliates. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx776938_9"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The validity of the shares of common stock offered by this prospectus has been passed upon for us by Pillsbury Winthrop Shaw Pittman LLP, Palo
Alto, California. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx776938_10"></A>EXPERTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The consolidated financial statements and financial statement schedule of TD SYNNEX Corporation and subsidiaries as of November&nbsp;30, 2022
and 2021, and for each of the years in the three-year period ended November&nbsp;30, 2022, and management&#146;s assessment of the effectiveness of internal control over financial reporting as of November&nbsp;30, 2022 have been incorporated by
reference herein and in the registration statement in reliance upon the report of KPMG LLP, independent registered public accounting firm, incorporated by reference herein, and upon the authority of said firm as experts in accounting and auditing.
</P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx776938_11"></A>WHERE YOU CAN FIND MORE INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have filed a registration statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> with the SEC under the Securities Act. This
prospectus is part of the registration statement but the registration statement includes and incorporates by reference additional information and exhibits. We file annual, quarterly and current reports, proxy statements and other information with
the SEC. Our SEC filings are available to the public on the internet at a website maintained by the SEC located at http://www.sec.gov. We also maintain an internet site at https://www.tdsynnex.com/ where information about us, including SEC filings,
is also available free of charge. However, the information on, or accessible through, our internet site is not incorporated by reference in this prospectus and any prospectus supplement and you should not consider it a part of this prospectus or any
accompanying prospectus supplement. Reference to our internet site is made as an inactive textual reference. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx776938_12"></A>INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The SEC allows us to &#147;incorporate by reference&#148; into this prospectus the information in other documents that we file with it. This
means that we can disclose important information to you by referring you to those documents. The information incorporated by reference is considered to be a part of this prospectus, and information in documents that we file later with the SEC will
automatically update and supersede information contained in documents filed earlier with the SEC or contained in this prospectus. We incorporate by reference in this prospectus (i)&nbsp;the documents listed below, and (ii)&nbsp;and any future
filings that we may make with the SEC under Sections 13(a), 13(c), 14, or 15(d) of the Exchange Act after the filing date of the registration statement of which this prospectus forms a part, as well as between the date of this prospectus and the
termination of any offering of common stock under this prospectus; provided, however, that we are not incorporating, in each case, any documents or information deemed to have been furnished and not filed in accordance with SEC rules: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001177394/000117739423000010/snx-20221130.htm">Form
 <FONT STYLE="white-space:nowrap">10-K</FONT></A> for the fiscal year ended November&nbsp;30, 2022, filed with the SEC on January&nbsp;
24, 2023 (the &#147;2022 Annual Report&#148;), including the portions of our Definitive Proxy Statement on <A HREF="http://www.sec.gov/Archives/edgar/data/1177394/000119312523025624/d450342ddef14a.htm">Schedule 14A</A> filed on February&nbsp;6, 2023
incorporated by reference into the 2022 Annual Report; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarters ended <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001177394/000117739423000033/snx-20230228.htm">February
 28, 2023</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001177394/000117739423000048/snx-20230531.htm">May<U></U>&nbsp;
31, 2023</A>, and <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1177394/000117739423000054/snx-20230831.htm">August&nbsp;31, 2023</A>; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001177394/000117739423000003/snx-20230104.htm">January
<U></U>&nbsp;10, 2023</A>; <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001177394/000119312523015619/d445931d8k.htm">January<U></U>&nbsp;
26, 2023</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001177394/000119312523019085/d455296d8k.htm">January<U></U>&nbsp;
30, 2023</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001177394/000117739423000027/snx-20230321.htm">March<U></U>&nbsp;
27, 2023</A> (as amended on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001177394/000117739423000039/snx-20230321.htm">June<U></U>&nbsp;
22, 2023</A>), and <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001177394/000119312523246482/d470040d8k.htm">September&nbsp;29, 2023</A>; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The description of our common stock contained in <A HREF="http://www.sec.gov/Archives/edgar/data/1177394/000156459022003003/snx-ex41_1326.htm">Exhibit
 4.1</A> of our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended November&nbsp;30, 2021, including any amendment or report updating such description. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All documents and reports that we file with the SEC (other than any portion of such filings
that are furnished under applicable SEC rules rather than filed) under Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act from the date of this prospectus supplement until the completion of the offering under this prospectus supplement shall be
deemed to be incorporated in this prospectus supplement and the accompanying prospectus by reference. The information contained on or accessible through our website at https://www.tdsynnex.com is not incorporated into this prospectus supplement or
the accompanying prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon request, we will provide, without charge, to each person, including any beneficial owner, to whom a
copy of this prospectus is delivered, a copy of any or all of the documents incorporated by reference into this prospectus but not delivered herewith. You may request a copy of these filings, other than an exhibit to these filings unless we have
specifically included or incorporated that exhibit by reference into the filing, from the SEC as described under &#147;Where You Can Find More Information&#148; or, at no cost, by writing or telephoning TD SYNNEX Corporation at the following
address: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">TD SYNNEX Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention: Corporate Secretary </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16202 Bay Vista Drive </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Clearwater,
Florida 33760 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(510) <FONT STYLE="white-space:nowrap">656-3333</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should not assume that the information in this prospectus or any documents incorporated by reference is accurate as of any date other than
the date of the applicable document. Any statement contained in a document incorporated or deemed to be incorporated by reference into this prospectus will be deemed to be modified or superseded for purposes of this prospectus to the extent that a
statement contained in this prospectus or any other subsequently filed document that is deemed to be incorporated by reference into this prospectus modifies or supersedes the statement. Any statement so modified or superseded will not be deemed,
except as so modified or superseded, to constitute a part of this prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:2.00pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:60pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>5,309,299 Shares </B></P>
<P STYLE="font-size:50pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g776938g04a04.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:50pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P> <P STYLE="font-size:50pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PROSPECTUS
SUPPLEMENT </B></P> <P STYLE="font-size:14pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:50pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><I>Book-Running Managers </I></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt">


<TR>

<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="14%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="26%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:12pt; font-family:Times New Roman"><B>J.P.&nbsp;Morgan</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Citigroup</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:12pt; font-family:Times New Roman" ALIGN="right"><B>Goldman&nbsp;Sachs&nbsp;&amp;&nbsp;Co.&nbsp;LLC</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><B>Mizuho</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><B>RBC&nbsp;Capital&nbsp;Markets</B></TD></TR>
</TABLE> <P STYLE="font-size:50pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>April&nbsp;4, 2024 </B></P> <P STYLE="font-size:60pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:4.5pt;margin-top:0pt;margin-bottom:2pt;border-bottom:2.00pt solid #000000">&nbsp;</P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g776938g04a04.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g776938g04a04.jpg
M_]C_X  02D9)1@ ! 0$ E "4  #_[10,4&AO=&]S:&]P(#,N,  X0DE-! 0
M    $_"^400X0DE-! 0      %<< 5H  QLE1QP"   "   < E  "&-G,#(R
M.#<T' (% #9-:6-R;W-O9G0@5V]R9" M(%1$(%-93DY%6" M(%,M,T%34E]-
M:51!0R!!<&]L;&]?+F1O8W@ .$))300E       0>E:V!(R.!=- 9DJ<C,"8
M<3A"24T$.@      \0   !     !       +<')I;G1/=71P=70    %
M %!S=%-B;V]L 0    !);G1E96YU;0    !);G1E     $-L<FT    /<')I
M;G13:7AT965N0FET8F]O;      +<')I;G1E<DYA;65415A4    !P!! %
M1  M "T ,@      #W!R:6YT4')O;V93971U<$]B:F,    , %  <@!O &\
M9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !     $)L=&YE;G5M
M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[      (M
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M9"!5;G1&(U)L=                %)S;'15;G1&(U!X;$!BO__@
M"G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0    !09U!S     %!G4$,
M    3&5F=%5N=$8C4FQT                5&]P(%5N=$8C4FQT
M        4V-L(%5N=$8C4')C0%D            08W)O<%=H96Y0<FEN=&EN
M9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P         ,8W)O<%)E8W1,
M969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<         "V-R;W!2
M96-T5&]P;&]N9P      .$))30/M       0 )3,S  !  ( E,S,  $  CA"
M24T$)@      #@             _@   .$))300-       $    6CA"24T$
M&0      !    !XX0DE- _,       D           $ .$))32<0       *
M  $          CA"24T#]0      2  O9F8  0!L9F8 !@       0 O9F8
M 0"AF9H !@       0 R     0!:    !@       0 U     0 M    !@
M     3A"24T#^       <   _____________________________P/H
M /____________________________\#Z     #_____________________
M________ ^@     _____________________________P/H   X0DE-! @
M     !     !   "0    D      .$))301$       0     @   D    )
M     #A"24T$'@      !      X0DE-!!H      T$    &
M  !D   ![0    8 9P P #0 80 P #0    !
M  $              >T   !D                      $
M            $     $       !N=6QL     @    9B;W5N9'-/8FIC
M 0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M        0G1O;6QO;F<   !D     %)G:'1L;VYG   ![0    9S;&EC97-6
M;$QS     4]B:F,    !       %<VQI8V4    2    !W-L:6-E241L;VYG
M          =G<F]U<$E$;&]N9P         &;W)I9VEN96YU;0    Q%4VQI
M8V5/<FEG:6X    -875T;T=E;F5R871E9     !4>7!E96YU;0    I%4VQI
M8V54>7!E     $EM9R     &8F]U;F1S3V)J8P    $       !28W0Q
M!     !4;W @;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG
M    9     !29VAT;&]N9P   >T    #=7)L5$585     $       !N=6QL
M5$585     $       !-<V=E5$585     $       9A;'1486=415A4
M 0      #F-E;&Q497AT27-(5$U,8F]O; $    (8V5L;%1E>'1415A4
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M971L;VYG       X0DE-!"@       P    "/_         X0DE-!!$
M  $! #A"24T$%       !     ,X0DE-! P     "4,    !    G@   "
M  '<   [@   "2< &  !_]C_[0 ,061O8F5?0TT  O_N  Y!9&]B90!D@
M  '_VP"$  P(" @)" P)"0P1"PH+$14/# P/%1@3$Q43$Q@1# P,# P,$0P,
M# P,# P,# P,# P,# P,# P,# P,# P,# P!#0L+#0X-$ X.$!0.#@X4% X.
M#@X4$0P,# P,$1$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,
M#/_  !$( "  G@,!(@ "$0$#$0'_W0 $  K_Q $_   !!0$! 0$! 0
M   #  $"! 4&!P@)"@L!  $% 0$! 0$!          $  @,$!0
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MW9#C@;3_ +NJD6[J+5N8%(=>K*VH=0E(4X2@[BF9290E"$F1 %A/-L=A_9M
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MJ<'J@C8*#_'0^O\ 'Z>=ZU[^=CA#N_TB3!^?3X<X6X_%;ZY''[8KWCQXW_\
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MF(*86H)E)41U,1\^?;![2<WS;5E-V>4=:O\ IV3-43=2SM<"JO,*L-U"DO+
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MGJS6V;/9J=/Z?=[JJ[]5.5H0E2U*;44K@K! N"(!DV)-X&N53Y-OQ"-I4O\
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M#C_>*#KKA<*E3N49)-R;_,S>YGRQV8RPW3,)IZ="&6D )2AM(2E(    %A
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M?XF7 ]?;IM.SSA6_,>3B&T5&NV7)B7C;+3H6EI<A$1U^!6V(B=+66F&9CJ
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M)*Y4ELOR-)1H(>=<6D@J/E>Q%JKLNTA7/J=J:!#)0H@AIUQA%_$2$-+2D2(
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MH\A4NC?E-8IM/JT:A>NW4@9_Q$5TQ2TE;'KJ#R5K;)XDU?G;-71+"U2Z4D&
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$@Q__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
